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Abstract 
The gametocyte surface antigens of Plasmodi urn falcipa rum appear to be immunogenic 
in only a proportion of the malaria-exposed population; this may explain the rather low 
levels of transmission-blocking immunity induced by natural infection. For example, 
about 40% of malaria-exposed individuals do not make antibodies to the native Pfs230 
molecule, a major transmission-blocking target antigen on the gametocyte surface. It is 
possible that poor immunogenicity of gametocyte antigens is due to immune modulation 
by the asexual blood stage of parasite infection. Establishment of a mouse model with 
limited specific anti-gametocyte immunity would be a 'useful tool to investigate the 
regulation of transmission-blocking immunity. The present study was designed to 
examine whether an on going immune response (induced by prior immunisation with 
an unrelated antigen or by concomitant asexual malaria parasitaemia) can influence the 
immune response to gametocyte antigens. The data indicate that in mice, PPD treatment 
prior to gametocyte immunisation results in considerable variability in the anti-M230 
antibody response. Further studies of this model may help us to understand the 
interactions between immune responses to unrelated antigens and assist in the rational 
design of malaria vaccines. 
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Chapter 1 Introduction 
Malaria, the most important parasitic disease in the world today, continues to be a 
major health problem in many developing countries and a common cause of infection 
among travellers (Cook 1988, Struchier 1989, WHO 1990). Every year, malaria 
causes clinical illness, often very severe, in over 100 million people and over 1 
million people die from it. It threatens 2200 million persons, about 40% of the 
world's population (WHO 1993). During the past 40 years, malaria control strategies 
have relied on insecticides against the mosquito vector and drugs for the prevention 
and cure of infection. These control methods are now becoming less effective with 
the world-wide spread of insecticide-resistant mosquitoes and malaria parasites that 
are resistant to antimalarial drugs. The emergence of resistance in both vectors and 
parasites has again emphasised that an effective malaria vaccine will be an essential 
component of future control-and-eradication schemes. One of the problems in 
developing a malaria vaccine is that this parasite has a very complex life cycle, and 
each stage bears different protective antigens. Another difficulty is that sufficient 
amounts of antigen can only be obtained by genetic engineering or chemical 
synthesis. In spite of these formidable obstacles, considerable progress has been 
made in the last few years, and a few candidate malaria vaccines have been tried in 
humans with partial success (Hoffman et al 1991, Nussenzweig et al 1989, Romero 
1992,). 
Malaria is a disease caused by repeated cycles of growth of the parasite 
Plas,nodiwn in the erythrocyte and the expression of disease is influenced by both 
parasite and host factors. There are four species of Plasmodiwn that infect humans, 
in order of decreasing world-wide prevalence, P. falciparwn, P. vivax, P. malariae 
and P. ovale (Miller et a! 1986). The disease is characterised by periodic fevers 
coinciding with the liberation of merozoites during the erythrocytic phase of the 
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infection; these fevers occur every 72 hours in the case of P.malariae and 48 hours 
in the other species. Although only infection with P. falciparwn is a potentially fatal 
disease, the fever, anaemia and risk of spontaneous splenic rupture associated with 
the other infections could have serious consequences for selected patients (Miller et al 
1994,Wyler 1993). 
1.1 Life cycle of malaria Darasites 
Knowledge of the life cycle of Plasinodium organisms provides the background 
for understanding of malaria. The life cycle of the malaria parasite involves a 
vertebrate host and mosquito vector (Figure I). It is easier to understand as a 
sequence of four phases: one sexual without multiplication, and three asexual with 
multiplication. The sexual and first asexual occur only in Anopheles mosquitoes. The 
second asexual phase is in the liver, the third in the blood. In the third phase some 
parasites become sex-cells, called gametocytes, which start a new cycle if taken into 
an Anopheles mosquito. 
The infection commences with the intravenous inoculation of sporozoites by 
infected mosquitoes. The sporozoites injected by mosquitoes are rapidly cleared in 
the liver, where they enter hepatocytes and transform into hepatic exoerythrocytic 
(EE) form. After about one week, merozoites are released from the primary EE forms 
into the circulation, where they invade erythrocytes and initiate the intraerythrocytic 
cycle. Probably only tens to hundreds of hepatocytes are targeted by sporozoites, and 
this stage is not responsible for any disease. The pathogenic process occurs only 
during the erythrocytic cycle. After merozoites invade erythrocytes, they begin to 
feed on haemoglobin, undergo further development, and replicate asexually in a 
process called schizogony. Schizonts and forms in the intermediary developmental 
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Figure I. Cycle of infection in human malaria. 
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blood smears. Schizogony progresses from the initial ring-form stage to the 
trophozoite stage to the schizont stage. The merozoites rupture out of the mature 
schizont-infected erythrocyte and invade adjacent uninfected erythrocytes (White and 
Ho 1992). 
Some merozoites develop within erythrocytes into the sexual stages, the male and 
female gametocytes. These infected erythrocytes are ingested by mosquitoes during a 
blood meal. In the gut of an Anopheles mosquito vector, gametocytes escape from 
erythrocytes to become free gametes. The male gamete produces up to 8 flagella in a 
sudden, violent exflagellation. If a female gamete is found then fertilisation produces 
a zygote. This develops into the invasive ookinete, which bores into the stomach wall 
and becomes an oocyst. Further development takes place in the gut wall, with the 
eventual production of sporozoites that then migrate to the salivary glands, where 
they remain poised for infection of the next bite victim. 
The life cycle of malaria parasites provides a variety of stages which are 
vulnerable to immune attack by their vertebrate host : sporozoites develop into 
merozoites within the liver, merozoites mature in erythrocytes from rings to 
schizonts, gametocytes differentiate and infect mosquitoes and the cycle in 
mosquitoes proceeds from gamete fertilisation to sporozoite production . As 
protective immune responses in malaria are largely stage-specific, there is a need to 
identify appropriate targets at each stage. Candidate vaccine antigens have been 
identified for each stage in the life cycle of the malaria parasite. There are four types 
of malaria vaccines: [1] anti-disease vaccine: to neutralise factors responsible for the 
pathology associated with malaria infection, [2] pre-erythrocytic stage vaccine: to 
block the development of incoming parasites, [3] blood stage vaccine: to limit the 
development of already established parasites, [4] sexual stage vaccine: to limit 
transmission of malaria by immune interference with the parasite's cycle of sexual 
development in the mosquito (Romero 1992). 
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1.2 Immune resDonses to snorozoite anti2ens 
Sporozoites are the infective stages of the parasite found in the salivary glands of 
female Anopheles mosquitoes. Malaria infection begins when sporozoites are 
injected by a mosquito directly into a blood vessel. The sporozoites circulate in the 
blood for a few minutes before entering the liver where the first phase of 
multiplication occurs. Sporozoites are therefore the first and ideal target for host's 
immune attack (Nardin and Nussenzweig 1993). 
1.2.1 Humoral immunity 
Sporozoites are covered by a polypeptide called circumsporozoite protein (CSP). 
The CSP of P.falciparwn contains a large, immunodominant central region 
consisting of tandemly repeated tetrapeptides (the repeat is basically composed of the 
sequence NANP with the variant NVDP), flanked by non-repeat regions 
(Nussenzweig et al 1985). Development of human subunit sporozoite vaccines has 
been based on the hypothesis that antibodies to the repeat region of the CSP will 
prevent sporozoite infection (Ballou et al 1987, Herrington et al 1987). People living 
in endemic areas have CS antibodies with biological activities that correlate with 
protection from sporozoite challenge (Hoffman et a! 1986). But later evidence 
revealed that circulating antisporozoite antibodies from natural exposure to 
sporozoites do not prevent malaria (Hoffman et al 1987). 
In animal models of malaria, it has been firmly established that antibodies to a 
repeat region present in the CSP mediate protection against sporozoite-induced 
malaria (Nussenzweig et al, 1989, Potocnjak et a! 1980). However, sera from 
sporozoite-immunised mice do not transfer protection even though the donor mice are 
themselves protected (Egan et al 1987). In mice, the anti-sporozoite immunity is 
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eliminated by depletion of CD81 T cell, not CD4 T cells, indicating that cytotoxic T 
lymphocytes (CFL) are required for this immunity (Weiss et a! 1988). Several trials 
of vaccines that induce antibodies against the central repetitive sequence of CSP in 
humans (Ballou et al 1987, Herrington et a! 1987) and mice (Egan 1987, Lal et al 
1987) have had limited success. This suggests that humoral immunity may be less 
important than previously thought and cellular immunity may be critical for a highly 
effective vaccine. 
1.2.2 Cellular immunity 
Mice (Kumar et al 1988, Romero et al 1989, Weiss et al 1990) and humans 
(Malik et a! 1991) immunised with irradiated sporozoites produce CD8 1 CTL against 
the CSP. It has been demonstrated in the mouse model following immunisation with 
CS-recombinant salmonella that CS-specific T cells, in the absence of antibody, can 
protect the mouse. Adoptive transfer experiments have demonstrated that cloned 
CD8 CTLs specific for the CSP conferred high level of protection (Romero et al 
1989). Recent studies demonstrate CD8 1 Cli against CSP can provide complete 
protection against malaria in the absence of other parasite-specific immune responses 
in mice (Khusmith et al 1994). These observations suggest specific CD8 1 CTL is an 
important factor in anti-sporozoite immune responses. 
The possible protective role of effector CD4 1 T cells also has been demonstrated 
by adoptive transfer of a P. berghei- specific CD4 T-cell clone that displays 
cytolytic activity in vitro (Tsuji et al 1990). Another study has suggested that both 
CD4 and CD8 T cells from mice inoculated with a CSP peptide could eliminate 
parasite-infected hepatocytes in vitro (Renia et al 1991). It is well recognised that 
distinct cytokine-producing subsets of antigen-specific CD4 1 cells mediate different 
immune responses (Mossmann and Coffman 1989). Previous studies showed that 
IFN-y (Ferreira et a! 1986, Schofield et a! 1987) and IL 6 (Pied et a! 1991) are 
important for immunity to malaria sporozoites. These observations indicated that 
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effector CD4 T cells may constitute a distinct anti-sporozoite immune mechanism 
that may act against parasites. 
1.2.3 Vaccines 
Vaccines based on the repeats of CSP have been developed (Ballou et al 1987, 
Herrington et a! 1987, Herrington et a! 1990), but the results were disappointing. 
Although CSP elicited good antibody responses, there was only limited protection 
(Greenwood 1990). Subsequent vaccine-design studies have concentrated on 
incorporating non-repetitive regions of the CSP, or using various combination of 
synthetic peptides based on the repetitive and the non-repetitive regions (Sinigaglia et 
al 1990). 
1.3 Immune resuonses to asexual blood stage antigens 
Merozoites released from the liver immediately invade erythrocytes within which 
they divide and multiply. Each merozoite yields between 8 and 16 further merozoites 
every 48 hours and these merozoites are released and invade further erythrocytes. 
This results in all the symptoms of malaria, ranging from the fevers that coincide 
with the release of merozoites, to anaemia and blockage of the brain capillaries by 
infected cells (Miller et al 1994). Most parasite antigens exposed to the immune 
system are derived from the asexual blood stages. A large number of blood stage 
antigens have been characterised at the molecular level. Recently the results of several 
vaccination trials using recombinant or synthetic blood stage products have become 
available. 
1.3.1 Humoral immunity 
The ring-infected erythrocyte surface antigen, Pf155IRESA, is a non-
polymorphic Plasmodiumfalciparwn polypeptide of 155 kD that is deposited in the 
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erythrocyte membrane during merozoite invasion (Collins et al 1986, Perlmann et al 
1988). Like most malaria antigens, Pf155IRESA contains repetitive regions and the 
majority of anti-Pf155IRESA antibodies are directed against these conserved repeat 
regions of the molecule. A number of vaccination trials included Pfl55IRESA-related 
immunogens and resulted in protective effects which correlated with antibody 
responses (Berzins et a! 1991, Collins et al 1986, Collins et al 1988). However, 
immunisation of Aotus monkeys with synthetic PfI55IRESA repeat peptides 
conjugated to diphtheria toxoid failed to induce protection (Collins et al 1991). 
One of the promising antigens for a blood stage vaccine is the merozoite surface 
protein-i (MSP1) (Holder 1988). The MSP1 of Plasmodiwn falciparwn isolates 
collected in geographically diverse endemic areas contains both highly polymorphic 
and highly conserved domains (Babiker et a! 1991, McBride et al 1985, Scherf et al 
1991, Snewin et a! 1991). MSP1 has been shown to induce partial or complete 
protection against a challenge with Plasmodium parasites in animal models (Diggs et 
al 1993). Some antibodies against MSP1 are known to inhibit invasion of 
erythrocytes by merozoites (Blackman et al 1990, Chang et al 1992, Pirson et a! 
1985) and have a direct inhibitory effect on parasite growth (Hui et al 1987) in vitro. 
Immunisation of rabbits with purified MSP1 with Freund's Complete Adjuvant 
(FCA) resulted in the production of antibodies that strongly inhibited parasite growth 
(Hui et al 1991). Recent studies show that the carboxy-terminus of MSP1 can induce 
protective immune responses to rodent malaria P.yoelii (Daly and Long 1993). The 
second merozoite surface protein (MSP2) varies in size between 45 and 55kD and 
contains a highly diverse central region of repeated amino acids (Marshall et al 
199 1).Anti-peptide antibodies recognised native MSP2 on the surface of the parasite 
and protection was observed in immunised mice after challenge with Plasmodiwn 
chabaudi (Saul et a! 1992). 
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1.3.2 Cellular immunity 
Several studies on murine experimental malaria have demonstrated that both the 
regulatory role and direct effector functions of T cells are important for antimalarial 
protection (Weidanz and Long, 1988). T cells may act as helper cells in the 
production of antiplasmodium antibody or trigger the cell-mediated mechanisms 
displayed by macrophages and by other phagocytic or cytotoxic cells. In vaccine 
trials in monkeys it has been demonstrated that animals can be protected in the 
absence of antibodies that block parasite invasion into erythrocytes (Butcher et a! 
1978, Miller et a! 1977). The role of T cells in protection from malaria probably 
relates to their ability to activate a population of monocytes which can mediate 
intracellular parasite death via the further liberation of monokines and oxygen free 
radicals (Clark 1987, Clark and Hunt 1983, Dockrell et a! 1983, Taverne et a! 1987). 
In mice, infected with blood-stages of P.chabaudi , Thi cells are associated with 
rapid recovery from the first peak of parasitaemia and Th2 cells with the long chronic 
phase and ultimate elimination of the parasite, mediated presumably by antibody 
(Langhorne 1989). 
Various blood stage antigens have been shown to activate T cells. Pf155IRESA 
has been shown to induce a specific T cell response in malaria-exposed donors. T 
cell responses to Pf155IRESA antigen include proliferation and lymphokine 
production and T-dependent B cell production of anti-Pf155IRESA antibodies 
(Kabilan et al 1988). The degree of protection induced by immunisation with a 
conserved MSP 1 recombinant polypeptide (190L) was significantly enhanced by the 
splicing of that region to a defined CS T helper cell epitope (CS-T3) (Herrera et a! 
1992). This enhanced protection correlated with elevated levels of circulating IFN-y 
at the time of challenge. IFN-y can inhibit the liver stage of Plasmodiwn (Ferreira et 
a! 1986). Recombinant MSP 2 proteins were capable of inducing proliferative and T 
helper cell responses in mice (Rzepczyk et a! 1992). 
1.3.3 Vaccines 
The merozoite stage seems to be the most suitable target of immune attack. It is 
merozoite infection of erythrocytes that is responsible for the clinical symptoms of 
infection, and in contrast to the sporozoite stage, which is only briefly present in the 
circulation before being sequestered in the liver cells, merozoites or merozoite-
infected erythrocytes are continuously exposed to antibodies and other components 
of the immune system in the bloodstream. Pf155/RESA and MSP1 are the two most 
studied blood-stage antigens in vaccine development and both of these antigens have 
been used in vaccine studies with variable success (Collins et al 1986, Hall et al 
1984, Perrin et a! 1984, Siddiqui et al 1987). All have produced similar results: the 
production of specific antibodies and limited, but incomplete protection in some, but 
not all, test animals. 
Synthetic SPf 66, a polymer built from a unit containing three short peptides 
representing sequences from three Plosinodium falciparum blood stage antigens, 
induces strong antibody responses in owl monkeys and is undergoing extensive field 
trials in humans (Patarroyo et al 1988). The magnitude of the humoral immune 
response induced in a total of 185 volunteers who received two immunisations of 
SPf 66 was found to be variable (Salcedo et al 1991). However, significant 
antipeptide serum IgG levels were detected in most of the individuals after receiving a 
third inoculation. Selected sera were shown to recognise several parasite derived 
polypeptides and, strikingly, to inhibit parasite growth in vitro. These results indicate 
that the SPI 66 vaccine is safe and immunogenic in humans.SPf 66 is being taken 
seriously by the WHO and other trials are under way. The results will not be known 
until July 1994, but they might well determine the future course of development of 
malaria vaccines (Cox 1993, Valero et al 1993). 
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1.4 Immune responses to sexual stage antigen 
Sexual differentiation of the malaria parasite begins with the formation of 
gametocytes in the bloodstream (gametocytogenesis). When the mosquito vector 
feeds, circulating gametocytes are taken up in the blood meal and differentiate into 
motile male microgametes and female macrogametes (gametogenesis). The gametes 
fuse in the mosquito midgut to produce a zygote which develops into an ookinete. 
The ookinete migrates through the gut wall to form an oocyst within which 
thousands of sporozoites are formed (Alano and Carter 1990; Carter et a! 1988; 
Sinden 1983). Only the sexual stage of the parasite carries the infection from humans 
to mosquitoes, and man is the only known reservoir of the disease. Therefore, 
disruption of the development of sexual-stage parasites in the mosquito midgut 
should prevent the spread of malaria (Kaslow et al 1992). "Malaria transmission-
blocking immunity" means immunity against the sexual and mosquito midgut stages 
of the malaria parasite. Transmission-blocking immunity would not afford direct 
protection to the recipient of the vaccine, but would protect other individuals in the 
vicinity from becoming infected from the immunised person. 
1.4.1 Humoral immunity 
Sexual stage antigens of malaria parasites have been studied in human and animal 
models. The biological and biochemical features of sexual stage antigens of the 
different species appear to be closely analogous. The antigens recognised by 
protective antibodies are the gamete, zygote surface antigens (Carter et al 1988). 
Antibodies either prevent gamete fertilisation or block zygote development in the gut 
of the mosquito after being taken up with gametocytes during a blood meal.Recent 
evidence suggests that complement-mediated lysis of gametes may be an important 
mechanism of transmission-blocking immunity (Read et al, in press). Gametes are 
not present in the human circulation, but they have many antigens in common with 
circulating gametocytes (Good et al 1987). These are the gamete/gametocyte surface 
proteins Pfs 230 (Quakyi et al 1987) and Pfs 48/45 (Rener et al 1983), the internal 
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sexual stage specific protein Pfg 27125(Wizel and Kumar 1991), and the 
zygotelookinete surface protein Pfs 25 (Vermeulen et al 1985). Although antibodies 
can block transmission, sera from 40% of humans living in endemic regions do not 
contain detectable levels of antibodies to the target transmission-blocking target 
antigens of P.falciparum (Carteret al 1989a, Graves et al 1988, Quakyi et al 1989), 
and about one-half of P.falciparwn gametocyte carriers are infectious to mosquitoes 
(Graves et a! 1988). In contrast to gametocyte surface antigens, the internal protein, 
Pfg27/25, is highly immunogenic (Carter et al 1989a). Therefore, the presence of 
antibody to Pfg27/25 is an indicator that the individual has been exposed to 
gametocytes (Riley et a! 1994a). 
1.4.2 Cellular immunity 
T cells appear to play a major role in the development of, or failure to develop, 
immunity to the sexual stages of malaria. Such immunity is mediated by a T cell 
dependent antibody response and by cellular mechanisms. There has been one report 
that immune CD4 T cells, upon adoptive transfer, can block transmission of malaria 
to the mosquito (Harte et al 1985). In a study from The Gambia it was found that T 
cells from malaria-exposed donors responded to a crude gametocyte antigen, whereas 
unexposed donors did not respond or responded only weakly to the lysate (Riley et al 
1990). In the same study, T cells from approximately 40% of the donors responded 
to affinity-purified Pfs48/45, whereas non-exposed donors were completely 
unresponsive to this antigen. On the other hand, cytokines also have the ability to 
inhibit gametocyte transmission (Naotunne et al 1991). 
1.4.3 Vaccines 
The aim of a malaria transmission-blocking vaccine is to arrest the sexual 
development of the parasite in the mosquito and to reduce or abolish malaria 
transmission levels, at least in certain epidemiological situations. The major emphasis 
of the development of transmission-blocking vaccines development is towards 
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eliciting a specific antibody response to transmission-blocking target antigens 
(Kaslow 1993). Pfs25, a 25kD protein on the surface of zygotes/ookinetes, is one of 
several P.falciparwn transmission-blocking vaccine candidates (Kaslow et a! 1988). 
Human sera from P.falciparwn endemic regions does not contain anti-25 kD 
antibodies, probably because humans are not exposed to this antigen. Mice 
immunised with zygotes generate anti-25 kD antibodies (Good et al 1988) suggesting 
that the protein would be immunogenic in humans if they were exposed to it. In 
contrast to antibody to Pfs230 and Pfs48145, antibody to Pfs25 can block 
transmission if present before or after fertilisation. A recent study has shown that a 
recombinant Pfs25 expressed in yeast appears to be a potent antigen and immunogen 
(Kaslow and Shiloach 1994). 
1.5 Tar2et anti2ens of transmission blocking immunity 
The sexual stages of Plasmodium , gametocytes in the vertebrate and gametes in 
the mosquito, express several antigens which can induce specific antibody 
responses. Antibodies against sexual stage-specific antigens are present in sera from 
humans exposed to malaria (Targett et a! 1990) and are induced in a variety of animal 
models (Carter et al 1988). Gametocytes inside red blood cells will not be affected by 
anti-gametocyte antibodies, but the antibodies can interact with the gamete surface 
antigens when parasites are released from infected erythrocytes (Alano 1991). 
Malaria transmission-blocking immunity is the concept that immunity can be 
induced in humans against the parasites that develop in the mosquitoes. It has been 
shown for several species of Plasmodium, that antibodies induced by immunisation 
or natural infection which are directed against gamete or zygote surface antigens, can 
inhibit development of the malaria parasite when ingested with the blood meal (Carter 
et al 1988). These antibodies are effective at three distinct points after gametogenesis 
13 
(1) prevention of fertilization by the antigamete antibodies (Vermeulen et a! 1985); 
(2) prevention of the transformation of ookinete into an oocyst (Vermeulen et al 
1985); and (3) prevention of the production of sporozoites within oocysts (Lensen et 
al 1992). 
Humans infected with malaria produce antibodies against the sexual stages of the 
parasite (Mendis et al 1987, Graves et a! 1988). These antibodies are evoked by 
gametocytes which are precursors of the sexual stages that presented to the host 
immune system during a blood infection. Parasite molecules that are targets of 
transmission-blocking antibodies have been defined in the major human malaria 
parasite P.falciparum (Carter et al 1988, Quakyi et al 1987, Rener et al 1983, 
Vermulen et a! 1985). Three molecules of gametocytes are targets of antibodies: the 
230 k (Pfs230) and the doublet 48/45 kD (Pfs48/45) proteins found predominantly 
on the surface of gametocytes/gametes and a cytoplasmic protein, Pfg27/25, which 
is expressed at the onset of gametocytogenesis.The genes coding for these 
gametocyte molecules have been cloned (Alano et a! 1991, Kocken et al 1993, 
Williamson et al 1993). Surface antigens, Pfs230 and Pfs48/45, function as targets 
of antigamete antibodies, but display limited immunogenicity in humans (Carter et al 
1989a, Graves et al 1988). The cytoplasmic antigen,Pfg27/25, is recognized by 
antibodies that can mediate transmission inhibition (Carter et al 1989b, Wizel et al 
1991). However the antigen is not surface exposed during sexual development, and 
the mechanism of this inhibition may be mediated by cross-reacting antigens. 
Pfs230 and Pfs48/45 are expressed on the cell surface of gametocytes/gametes. 
Some monoclonal antibodies directed against one or the other of the 230, 48 or 45kD 
polypeptides can immunoprecipitate all three peptides suggesting that these three 
polypeptides form a non-covalent but stable complex on the surface of gametocytes 
and gametes (Kumar and Wizel ,1992). These antigens can be divided into two 
groups by using differential detergent extraction. Pfs230 molecules are hydrophilic, 
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while Pfs48145 are lipophilic and presumably contact the membrane more tightly than 
Pfs230 (Kumar 1987). Antibodies against these gametocyte surface antigens can 
prevent fertilization and therefore block parasite transmission through the mosquito; 
they have no effect once the zygote is formed. It has been demonstrated that the 
antibody response to Pfs230 molecules is made during infection (Graves et al 1988) 
and the mechanism of action of anti-Pfs230 antibody is complement-dependent (Read 
et al,in press). It has also been noted that the antibody response to Pfs230 and 
Pfs48/45 is quite variable in human populations (Carter et al 1989a, Premawansa et 
al 1994, Riley et al 1994a, Targett et al 1990). About 40% of malaria patients do not 
make antibody against native Pfs230 molecule. This phenomenon is consistent over 
time and fixed in early life but not associated with liLA genotypes (Graves et al 
1989, Riley et a! 1990, Riley et al 1994a). Positive correlation between anti-Pfs230 
antibodies and the transmission-blocking capacity of human sera (Graves et al 1988) 
suggests that a vaccine based on Pfs230 would be boosted by a malarial infection. 
Pfs25 is a lipophilic molecule (Kumar 1985) and the predominant antigen on the 
zygote/ookinete surface. Antibodies against this antigen can completely suppress the 
subsequent development of the parasites (Vermeulen et al 1985) and efficiently block 
transmission of the parasite through the mosquito. More than 10% of the native 
Pfs25 protein is composed of cysteine residues and may form a network of 
disulphide bonds giving a structure that is similar to epidermal growth factor (EGF) 
(Kaslow et a! 1988). The EGF-like domains of Pfs25 are very conserved (Kaslow et 
al 1989) and their function might participate in establishing cell-cell contact for the 
migrating ookinete. Antibodies against this antigen, without the help of complement, 
prevent the migration of the ookinete (Vermeulen et a! 1985). 
Pfg27125 is an intracellular protein and not detectable on the surface of gametes 
(Carter et a! 1989b). But this antigen is an effective immunogen in that all malaria 
exposed individuals make antibodies to it (Riley et al 1994a) and it can be considered 
15 
as an indicator for exposure to sexual stage antigens. A previous study showed that 
monoclonal antibody which recognized Pfg27t25 almost completely blocked 
transmission in the presence of added complement (Wizel and Kumar, 1991). 
1.6 Limited immune responses to malaria sexual stage antigens 
Not all parasite antigens have the capacity to induce protective immunity. 
Usually, surface antigens of the parasite are easily exposed to immune attack. If an 
antigen has been identified, and antibodies against it can block parasite development 
in vitro, it would seem reasonable to assess its capacity as a vaccine. The gametocyte 
surface antigens, Pfs230 and Pfs48/45, have been demonstrated to be major targets 
of transmission-blocking antibodies (Rener et al 1983, Vermeulen et al 1985, Quakyi 
et al 1987). Furthermore, antibodies to Pfs230 have been reported to correlate with 
transmission-blocking activity in sera collected from humans living in malaria-
endemic regions (Graves et al 1988). Pfs230 is therefore considered to be a good 
candidate for a transmission blocking vaccine antigen. But studies show limited 
immunological recognition of Pfs230 and Pfs48145 in human populations (Carter et 
al 1989a, Graves et al 1989, Premawansa et al 1994, Riley et al 1994a) and different 
congenic strains of mice (Good et al 1988). About 40% of malaria-exposed 
individuals do not make antibodies to the Pfs230 molecule. This nonresponsiveness 
does not appear to be related to individual differences in exposure to malaria or to 
gametocytes in particular since all individuals in one study responded to crude blood-
stage antigen, and about 60% patients responded to the 230 kD antigen (Carter et al 
1989a, Quakyi et al 1989). This phenomenon is stable over time and may be a feature 
of natural target antigens of antimalarial immunity (Riley et al 1994a). Previous 
studies suggested that there is MHC restriction of the immune response to the gamete 
surface antigens (Carter et al 1989a; Good et a! 1988), although recent research 
indicates that the induction of anti-Pfs230 antibody is neither genetically controlled 
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nor MHC-limited (Graves et al 1989, Riley et al 1994a). Pfs230 could be a potent 
vaccine antigen, but limited immunogenicity may be a significant problem for 
induction of transmission-blocking immunity. 
1.7 Aims of the study 
The aim of this study was to investigate the hypothesis that the lack of anti-
Pfs230 antibody in malaria-exposed individuals might be due to differential 
regulation of the immune response to gametocytes. 
In recent years it has become clear that the type of antigen-specific immune 
response is largely dependent on selective activation of subsets of CD4 helper T 
cells (subset 1 (Th 1) and subset 2 (Th2)) which are able to secrete defined patterns of 
cytokines, leading to the triggering of different effector mechanisms. ml cells 
produce IL-2 and IFN-y and little or no IL-4, IL-5 or IL-b, whereas Th2 cells 
demonstrate the opposite pattern (Romagnani 1994). Distinct cytokine profiles have 
been described for T cell responses to microbial pathogens (Sher and Coffman 
1992). Thi responses are characteristically associated with resistance to, and 
elimination of, intracellular pathogens such as Mycobacteriwn tuberculosis and 
Leishmania major. On the other hand, Th2 responses are elicited by helminthic 
parasites and correlate with protective immunity to several species of parasitic 
nematodes (Del Prete et al 1991). In leishmaniasis, Thi cells develop after infection 
of resistant mice and mediate protection, while Th2 cells are stimulated in the 
susceptible BALB/c mouse (Locksley et al 1991). In murine malaria, mi cells 
predominate during the initial stages of infection, but are replaced by Th2 cells during 
the latter stages of infection (Langhorne 1989). In view of these preliminary results, 
T helper cell subsets and different patterns of cytokine production may play a key 
role in the regulation of malaria infection. 
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Recent studies suggest that primary stimulation conditions affect the cytokine 
production profiles of cultured T cells in vitro. The inhibiting effect on IL-4 
production by PMA on freshly isolated T cells seems irreversible (van der Pouw-
Kraan et a! 1993). An alternative study is to investigate whether ongoing Th 
responses to one set of microbial antigens can influence the Th response to unrelated 
antigens. PPD, an antigen which leads to induction of Th 1 cells (Del Prete et al 
1991), can in fact induce Th2 type immune responses under the modulation of an 
ongoing helminth-induced Th2 immunological condition (Pearlman et a! 1993). 
These results suggest that the immunological status created by primary stimulation 
can influence the response to subsequent challenge and may even alter the immune 
response to an unrelated antigen. 
In malaria endemic regions, only 60% of immune human sera contain antibodies 
to the Pfs230 gamete surface antigen (Carter et al 1989a,Graves et al 1989, 
Premawansa Ct al 1994, Riley et a! 1994a). This phenomenon is stable over time and 
does not appear to be related to MHC or other genetic factors (Graves et al 1989, 
Riley et al 1994a). These observations led to the hypothesis that the limited 
immunogenicity of Pfs230 is due to primary exposure to malaria asexual stage 
antigens that affect the subsequent immune response to sexual stage antigens. Several 
studies have established that the blood stages (rings, trophozoites, schizonts, 
merozoites) of this intracellular protozoan cause changes in almost every component 
of the immune system (Riley Ct al 1994b). It is possible that the ongoing immune 
responses induced by asexual stage parasites during infection may modulate the 
subsequent immune response to gametocytes. 
In this study, I have attempted to establish an experimental model which 
reproduces the limited immunogenicity observed in humans, to study the possible 
mechanisms for the apparently poor immunogenicity of the gametocyte surface 
antigens. My results show that BALB/c mice immunised with gametocyte-infected 
erythrocytes in adjuvant make a uniform antibody response to Pfs230. However, 
pretreatment of naive BALB/c mice with PPD prior to gametocyte immunisation 
results in very variable immune responses with some mice not making antibody 
against Pfs230. These data indicate that immune responses to gametocyte antigens 
are affected by the ongoing immune responses induced by PPD. This variable 
antibody response is similar to the variable human antibody responses seen in malaria 
endemic regions. These results allow us to consider whether the ongoing 
immunological condition created by asexual malaria infection is an important factor in 
regulation of immune responses to sexual stage antigens. Furthermore, we can 
assume that immune responses to every stage in the parasite's life cycle (sporozoite-
merozoite-gametocyte) might be modulated by each other. The results in this study 
suggest that this mouse model could be a useful tool to investigate the restriction of 
transmission-blocking immunity. Further studies of this model may help us to 
understand the interactions between immune responses to unrelated antigens in 
malaria infection and assist in the rational design of malaria vaccines. 
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Chapter 2. Experimental Materials and Methods 
2.1 Parasite materials - Plasmodium falcinarum 2ametocvtes 
2.1.1 Introduction 
Malaria research has benefited considerably from technical advances in the 
culture systems of Plasmodium parasites. Intraerythrocytic stages of Plasmodium 
falciparwn have been studied in continuous culture (Trager and Jensen 1976) and 
gametocytes developing in such cultures were shown to be infective to mosquitoes 
(Carter and Beach 1977, Ifebida and Vanderberg 1981). Gametocyte induction has 
been shown to occur more readily when the cultures are maintained for extended 
periods of time without the addition of fresh uninfected erythrocytes. Their 
development progressed in a consistent pattern, from small round, through 
triangular, to ellipsoidal, and finally to crescentic forms (Jensen 1919). The 
gametocytes of P.falciparwn usually appear as a sudden wave of mature crescents 
about 10-12 days after the asexual stages. 
2.1.2 Culture method 
Plasmodiumfalciparum clone 3137 was cultured in 6% haematocrit RPMI 1640 
culture medium with HEPES buffer and 10% human serum, maintained in 
continuous culture in vitro (Trager and Jensen 1976, Ifebida and Vanderberg 1981). 
Gametocyte producing cultures were set up initially at 0.5% parasitaemia in 75 cm2 
tissue culture flasks by subculturing from stock cultures in an atmosphere of 1% 02. 
5% CO2 and 94% N2 at 37°C. Culture medium was changed daily and gametocytes 
were maintained for at least 14 days without subculturing and harvested when they 
had a 2-5% parasitaemia and at least 60% of the parasites were mature gametocytes. 
The mature gametocytes were harvested and enriched on a discontinuous Percoll 
gradient (30%, 45%,52.5%) at 10,000 rpm for 10 minutes at room temperature. The 
material at the gradient interfaces was removed and checked by phase contrast light 
microscopy. The gametocytes were resuspended in incomplete RPMI medium and 
washed at least once to remove Percoll. The preparation was used immediately for 
the purpose intended or pelleted in a microcentrifuge tube and frozen as a dry pellet 
after removal of the supernatant. 
2.2 Prenaration of labelled surface anti2en from 2ametes 
2.2.1 Introduction 
The cell surface proteins play an important role in the generation of immune 
responses. Direct purification of membrane proteins is difficult to achieve because of 
the low concentration in the cell, but labeling the antigens with radioactive isotopes 
has made it possible to study these proteins. Specific antisera against the antigens can 
be used to isolate the radiolabeled proteins from detergent extracts of the cells and the 
proteins can be characterized by a variety of electrophoretic procedures. Outer surface 
proteins of the intact cell can be labelled with 1251. These radio-labelled antigens, 
reacted with monoclonal antibodies, with subsequent analysis of the immune 
complexes by electrophoresis are used to study the location, activity and function of 
antigens. 
2.2.2 Materials and methods 
Purified gametes were surface radioiodinated by the iodogen reaction method 
with 1 tCi of Na 1251 (Howard et al 1982). Mature gametocytes were collected and 
stimulated to undergo gametogenesis for 1 hour by resuspension at a 20% hematocrit 
in a GSMJMEF (gametogenesis stimulating medium/mosquito exflagellation factor 
[Nijhout 1979], Appendix 1) solution at room temperature. Gametogenesis was 
monitored by periodically examining 10 tl wet smears from the suspension by phase 
contrast light microscopy. The suspension was placed on a Nycodenz gradient 
consisting of 3 steps of 16%, 11 % and 6% of Nycodenz in medium 199 and spun at 
10,000 rpm for 10 minutes (Vermeulen et al 1985). From the gradient, purified 
Plcsmodiuinfalc,parum gametes were collected and were washed twice in incomplete 
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medium , discarding the supernatant. The pellet was resuspended in 500 ptl PBS 
and put into an lodogen tube. 500 piCi sodium 125  Iodide was added to the tube 
which was agitated for 5 minutes. Unbound 1251  was removed by microcentrifuging 
and washing twice in non-lysis PBS. The pellet was harvested to a clean tube and 
washed twice (Carter et a! 1989a). 
2.3 Immunonrecinitation 
2.3.1 Introduction 
Radiolabeled cells are extracted with a detergent that effectively solubilizes 
membrane proteins without destroying their antigenicity. The most convenient way to 
prepare soluble cell extracts is to use an isotonic buffer containing non-ionic 
detergents such as Triton X-100. The detergent solubiizes extra- and intra-cellular 
membranes, and all soluble proteins including nucleoplasmic proteins are released. 
Usually, the lysis buffer is supplemented with reducing agents and protein inhibitors 
to prevent degradation of proteins during extraction. Antisera are added to the 
extracts to bind the desired antigen. The antigen-antibody complexes are then 
removed from solution by a protein A adsorbent. Protein A molecules have high 
adsorption capacity for the IgG molecules of many mammalian species, binding to 
the Fc fragment and leaving the antigen-combining sites free. Immune complexes are 
rapidly taken up and, once bound, cannot be displaced by normal IgG or by the 
addition of more antibody. Antigenic protein can be extracted by SDS sample buffer 
for analysis by electrophoresis. 
2.3.2 Materials and methods 
The surface-labelled gametes were extracted in NET!' (0.15M NaCl, 5mM EDTA, 
50mM Tris, 0.5% Triton, pH 7.4, Appendix 3) with protease inhibitors (TPCK, 
PMSF, OPA, IODOA; Appendix 5) (Kumar and Carter 1984) and the supernatant 
was collected. The labelled gamete protein preparations were diluted in NET!' with 
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protease inhibitors. Each preparation was absorbed with protein-A-sepharose beads 
to remove non-specifically binding materials before using the labelled antigen 
preparations for immunoprecipitation. The antigen extract was used for 
immunoprecipitation with 50 il of immune sera or monoclonal antibody (MAb) as 
positive control. The mixture was incubated for 1 hour at room temperature and 100 
tl of a 25% suspension of protein-A-sepharose (Appendix 7) in lml NET!' added 
and incubated overnight at 4°C with rocking. Following incubation, the protein-A-
sepharose beads were washed twice with NET!' plus 0.5M NaCl and twice with 
NET!' in a fresh tube. 
2.4 	Sodium 	dodecvl 	sulphate 	(SDS)-nolyacrylamide 	eel 
electrophoresis (PAGE) 
2.4.1 Introduction 
Estimation of the molecular weight of a polypeptide is of central importance to the 
characterisation of proteins. Molecular weight can be determined by the relative 
mobilities of the polypeptides using SDS-PAGE. Samples to be run on SDS slab 
gels are prepared in SDS sample buffer, which results in denaturation and 
solubiization of all the proteins. The protein mixture is boiled and applied directly to 
SDS gels for subsequent analysis. 
2.4.2 Materials and methods 
The Protein-A sepharose beads were extracted in sample buffer (without 
reducing agent) and the extracts separated on SDS-PAGE on 5-15% acrylamide 
gradient gels. Gels were dried on Whatman CF 11 filter paper and autoradiographed 
(Graves et at 1988; Rener et al 1983). 
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2.5 Immunisation and infection protocol 
Animals: Female BALB/c mice were obtained from OLAC, U.K. and maintained 
under standard conditions. These mice were used between 7 and 12 weeks of age. 
Gametocyte immunisation: Mice were primed with a intraperitoneal (i.p) injection 
of 3x106 gametocytes suspended in 10Otl of PBS and emulsified in an equal volume 
of Freund's Complete Adjuvant (FCA) followed by second and third i.p. injection of 
gametocytes emulsified in Freund's Incomplete Adjuvant (FIA). 
Plasmodium chabaudi adami infection: Mice were given an intraperitoneal 
injection of lx 106  Plasmodiwn chabaudi adami parasites. The parasitemia, estimated 
from tail vein blood smears, was measured by Giemsa-stained method. 
Serum collection: Each mouse was tail-bled before the first immunising injection 
to prepare nonimmune serum. Each mouse was also tail-bled before second and 
third immunisations to prepare serum on each occasion. Each of these sera was then 
diluted 1:10 v/v with PBS (pH 7.4, 0.1% NaN3) and stored at 4°C in eppendorf 
tubes until further use. 
2.6 Delayed-type hypersensitivity (DTH) 
2.6.1 Introduction 
As opposed to antibody-mediated hypersensitivity, delayed-type-hypersensitivity 
(DTH)is a T-cell-dependent reaction characterised by a delayed inflammatory reaction 
(peaking 24-48 hours after injection) at the site of antigenic challenge. Experimental 
models of DTH usually employ sensitization of animals with protein antigens 
emulsified in complete Freund's adjuvant (FCA) with DTH reactivity lasting for 
months. In the mouse, antigenic challenge is performed on the ears or footpads. 
DTh is quantified with an engineer's micrometer by measuring incremental swelling 
in the ears or footpads due to mononuclear cell influx, 24 hours after antigenic 
challenge. 
2.6.2 Method 
One week after the second injection of gametocytes, 10 5 gametocytes in PBS 
were injected to the right footpad and PBS only into the left footpad as control. 
Footpad thickness was measured before challenge, and at 24 hours after challenge 
using a dial-gauge calliper. The footpad swelling is expressed as the difference 
between the thickness of the experimental foot and the thickness of a foot injected 
with PBS alone. Data are presented in units of 10 - inch ± S.D. A two-tailed 
student's t-test was performed on the data presented and significance was assumed at 
p<=O.05. 
2.7 Lymohogroliferative resDonse: 
2.7.1 Introduction 
Proliferation of lymphocytes in response to mitogens or antigens is used as a 
measure of the functional status of these cells. Several assays have been reported to 
quantify cellular proliferation. Despite the availability of non-radioactive assays, the 
[3H]thymidine incorporation assay for DNA synthesis is still the most commonly 
employed assay because of its sensitivity and relative reliability. Several mitogens 
selectively stimulate different lymphocyte subpopulations. Both Concanavalin A 
(ConA) and phytohaemagglutinin (PHA) can cause proliferation of significant 
fractions of T cells in the presence of accessory cells. On the other hand, 
lipopolysaccharide (LPS) is specific for B lymphocytes. 
2.7.2 Materials and methods 
Mouse spleens were collected after 1-2 weeks after the final gametocyte 
immunisation. Single spleen cell suspensions were prepared by gently scraping apart 
the splemc tissue. After centrifugation, the RBC were lysed by hypotonic shock. 
Mononuclear cells were extensively washed and seeded into 96-well round bottom 
plates at a concentration of 1x10 5 cells/well in 0.1 ml tissue culture medium 
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RPM 164O supplemented with 10% heat-inactivated FCS. Cells were cultured with 
ConA (4ig/ml), PHA (5igIm1), PPD (200U/ml), uninfected RBC and gametocyte 
extract (100ilIwell) for 72 hours at 37 0C in an atmosphere of 5% CO2. On day 3, 
100ptl supernatant was collected from each cell before 1 iCi H] thymidine in 100tl 
fresh medium was added to the wells. After 18hrs the cells were harvested and PHI 
thymidline incorporation was determined by standard liquid scintillation counting and 
expressed as counts per minute (cpm). The optimal time for the proliferative assay 
was determined by a time course assay; cells were cultured with media, ConA, 
uninfected RBC and gametocyte for 2 days, 4 days, 6 days and 8 days. 
Lymphoproliferative responses were measured in triplicate and the geometric 
mean kcpm was calculated. Results are expressed as a stimulation index (kcpm of 
Ag-stimulated cultureslkcpm of unstimulated cultures). 
2.8 Cvtokine assays 
2.8.1 Introduction 
Direct measurement of cytokine production in vitro may be performed by analysis 
of lymphocyte culture supernatants after appropriate stimulation. One limitation of 
this method is that it will measure only the excess cytokine that remains in the 
supernatant after the requisite amounts have been utilized by the cells. 
Cytokines can be measured directly by enzyme-linked immunosorbent assay 
(ELISA). The most reliable and sensitive method so far appears to be a sandwich-
ELISA, in which an anti-cytokine antibody is bound to a 96-well plate, following 
which the cytokine is bound to the antibody, and a second anti-cytokine antibody is 
added for detection of bound cytokine. Enzyme-conjugated antibody against the 
second antibody can be used as a final step. The ELISA has an advantage over 
bioassays in that it is much less sensitive to inhibitory or interfering effects from 
column buffers or complex biological samples such as serum. The only drawback of 
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the monoclonal antibody ELISAs is the fact that they measure antigenically active 
protein, not necessarily biologically active cytokine. 
2.8.2 Materials and methods 
Freshly isolated spleen cells were cultured in RPMI 1640 medium with 10% FCS 
at 1x106 cells/ml in flat-bottom (lmLfwell) wells. Medium, ConA (10tgIml), LPS 
(10ig/ml), uninfected RBC and gametocyte extract were used as stimulators 
(100t1Jwell). After 24 hours, 48 hours and 72 hours culture, the supernatants were 
harvested and stored at -70°C until assaying. 
Concentrations of IFN-y, IL-2, IL-4, IL-5, and IL-10 in the culture were 
determined by a sandwich ELISA using purified anti-mouse cytokine mAb 
(Pharmingen, U.K.) to coat the microtitreplate and biotinylated anti-mouse cytokine 
mAb (Pharmingen, U.K.) as detecting antibodies. Cytokine levels were calculated by 
reference to standard curves (Appendix II) of known amounts of rIFN-y, rIL-2, rIL-
4, rIL-5, and rIL-10 (from Dr.Paul Garside, University of Glasgow). Bound 
enzyme was detected with o-phenylenediamine dihydrochloride (OPD) (Sigma 
Immuno Chemicals) and absorbance read at 492 nm. 
2.9 Antibody assay by ELISA 
2.9.1 Gametocyte protein (GP) purification 
The mature gametocytes were harvested and enriched on a discontinuous Percoll 
gradient (30%, 45%, 52.2%) at 10,000 rpm for 10 minutes at room temperature. The 
material at the gradient interfaces was removed and checked by phase contrast light 
microscopy. The gametocytes were resuspended in incomplete RPMT medium and 
washed at least once to remove Percoll. The gametocyte pellet (3x 107  gametocyte) 
was dissolved in 1 ml NETTI (Appendix 1.5) with protease inhibitors and agitated 5 
minutes and spun at 16,000 rpm for 10 minutes. Supernatant was collected and kept 
in -70°C. 
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2.9.2 Serum specific antibody 
Specific antibodies to PPD and GP in the immune sera were determined by an 
ELISA using PPD or GP to coat the microtitreplate and peroxidase-conjugated rabbit 
anti-mouse immunoglobulin MAb (Sigma Immuno Chemicals) as a detecting 
antibody. Bound enzyme was detected with OPD and absorbance read at 492 nm. 
2.9.3 Specific IgG subclass concentration 
Specific IgG to PPD and GP were determined by ELISA using PPD and GP as 
coating antigens. Goat-anti-mouse IgGl/2a/2b/3 (Nordic, U.K.) and rabbit-anti-
goat-Ig-HRP (Sigma Immuno Chemicals) are detecting antibodies.The concentration 
of IgG subclass were calculated by reference to standard curves (Appendix II) of 
known amounts of IgGl/2a/2b/3. 
2.10 Statistical analysis 
Data from lymphoproliferative response and DTH assays were expressed as the 
mean plus or minus the standard deviation (S.D.). A two-tailed Student t-test was 
used to determine significant differences between control and experimental groups. 
Differences were considered statistically significant when the p value was less than 
0.05. Statistical analysis in cytokine assays was performed using Mann-Whitney U-
test. Differences were considered statistically significant when the p value was less 
than 0.05. 
Chapter 3 Gametocyte immunisation induced specific 
cellular and humoral immunity 
3.1 Introduction 
It has been shown previously that specific humoral immune responses can be 
induced in mice immunised with Plasmodium falciparum sexual stage parasites. 
Antibody responses to the 25kD antigen, zygote/ookinete surface antigen, are found 
in different congenic strains of mice immunised with purified gametes (these gametes 
were further incubated for 5 hours to allow zygote formation, Good et al 1988). In 
contrast to the widespread antibody responses to Pfs25, most strains were 
nonresponsive to either the 230kD or 48/45kD molecules, gametocyte/gamete surface 
antigens. Although there was some variation within strains, most of the variation was 
between strains. 
Earlier work in our laboratory (Begarnie, 1991) showed that different congenic 
and inbred strains of mice, immunised with purified gametes, generated variable but 
not restricted antibody responses to gamete surface proteins. Mice from all the strains 
developed antibodies against major surface antigens, Pfs230 and Pfs48145. But 
varying degrees of responsiveness were seen within the same strain. These 
differences, within congenic/inbred mice which are genetically identical, implies that 
other factors, besides MHC molecules, may influence the production of antibodies to 
the major surface antigens in transmission-blocking immunity. 
Both of the previous studies show that antibody responses to gamete surface 
antigens are quite variable. This phenomenon is similar to the limited antibody 
response to transmission-blocking target antigens observed in humans. In this study, 
BALB/c mice were immunised with another sexual stage, purified gametocytes, and 
gametocyte-specific cellular and humoral immune responses were assessed. Our data 
indicate that gametocyte immunisation results in significant antibody responses 
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against gamete surface antigens and purified gametocyte proteins and gametocyte-
specific cellular immune responses. These responses were relatively consistent in all 
the mice immunised, implying that gametocytes could be a better immunogen to elicit 
transmission-blocking immunity than gametes. 
3.2 Experiment 
Each of the mice in the experimental group was given a first intraperitoneal 
injection of 3x106 clone 3D7 Plasmodiwn falciparwn gametocytes, suspended in 
100 t1 of PBS and emulsified in an equal volume of Freund's Complete Adjuvant 
(FCA), followed by second and third intraperitoneal injections of the same number of 
gametocytes emulsified in Freund's Incomplete Adjuvant (FIA), 14 and 28 days 
later. Control mice were immunised with PBS in FCA and HA instead of 
gametocytes. The delayed-type hypersensitivity (DTH) response was assayed 7 days 
after the second injection, and the mice were killed 14 days after the third 
immunisation. This schedule is summarized as follows: 
kill mice 
first 	 second 	 third 	lymphoproliferation 
immunisation 	immunisation 	DTH immunisation 	cytokine assay 
I-----------------------I-----------------I--------------I---------------------------I 
day 	 14 	21 	28 	 42 
serum serum 	serum 	serum serum 
collection 	collection 	collection collection 	collection 
fi 
3.3 Result 
3.3.1 Analysis of antibodies produced in mice immunised with P.falciparwn 
gametocvtes 
Serologic responses to P.falciparum gametocytes. Individual serum samples 
were taken from mice after immunisation with the P.falciparum gametocytes and 
were tested for antibody to gametocytes. Circulating serum antibodies to purified 
gametocyte protein (GP) were detectable by the ELISA (Fig. 1,a). Furthermore, the 
IgG subclasses induced by the gametocytes were IgGl>IgG2a>IgG2b>IgG3 
(Fig. lb). This result implies that gametocytes can induce specific antibody and these 
serum antibodies were predominantly IgGi. 
Serologic responses to gamete surface target antigens of transmission-
blocking iantibodies. The antigens recognised by the immune mouse serum were 
analysed by immunoprecipitation with gamete surface antigens. The profile of 1 251 
labelled antigens recognised by immune and control mouse serum is shown in Fig.2. 
The major gamete antigens immunoprecipitated by the immune BALB/c serum were 
at 230, 48/45, 40, and 27/25kD. All sera precipitated a uniformly strong band at 
230kD, while there was some variation in the intensity of the 48/45 and 4OkD bands. 
Control sera from PBS-immunised mice were unresponsive to the antigens. 
3.3.2 Delayed-type hypersensitivity (DTH) responses to P.falciparwn 
gametocytes 
Mice that had been immunised intra-peritoneally (i.p.) with P.falcipa rum 
gametocytes were tested for DTH responses to freeze/thawed gametocyte lysates. All 
mice immunised with gametocytes had a positive reaction to gametocyte challenge. 
Control mice showed no response to gametocyte (Table 1). The difference between 
the two groups is highly statistically significant. 
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Figure 1. Specificity of anti-gametocyte antibody and pattern of IgG subclasses in 
sera. Serum samples were obtained from mice two weeks after the third 
immunisation with either gametocytes (n=8) or PBS (n=8). The immune sera were 
tested for anti-gametocyte specificity by ELISA using purified gametocyte protein 
(GP) as coating antigen. Specific anti-UP antibody was found in the immune sera 
from gametocyte-immunised mice (a). The anti-UP antibodies were predominantly 
























Figure-2 Recognition of 1251 labelled Plasmodium falciparum 
gamete surface 
antigens by immune BALB/c serum. Serum samples were obtained from mice two 
weeks after the third immunisation with either gametocytes or PBS. Autoradiograph 
of 1251 labelled gamete surface antigens immunopreipitated with serum from 
gametocyte-imniuned BALB/c mim and control mi€e. ZT were 
mixed with serum for 1 hr at room temperature and immune eomhixes precipitated 
with Protein-A sepharose and analysed on a 5-15% gradient gel. Molecular weight 
markers are shown as the left hand side. The strong band at approx 100-1 lOkD 
probably represents degraded Pfs230. 
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n 	t 	p 
	
10 	3.13 	0.005 
8 	1.02 	0.2 
Table 1. DTH response to gametocyte antigens in gametocyte-immunised 
and control mice. After the second immunisation, the DTH response 
was elicited by injection of 10 gametocytes  into the right footpad and 
PBS only into the left footpad. Twenty-four hours later, the DTH 
response was determined by measuring the thickness of the footpad. Data 
are presented as the mean thickness, in unit of iO inch ± S.D. The 
difference between the thickness of the left and right footpads was 
assessed by Student's t-test. 
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3.3.3 Proliferative response of lymphocytes 
The proliferation of spleen cells from mice immunised with gametocytes or PBS 
was assayed in response to gametocyte antigens, mitogens and an unrelated antigen, 
PPD. Lymphocytes from gametocyte-immunised mice responded to gametocyte 
stimulation in a dose-dependent manner (Fig.3). The proliferative response was 
maximal at the highest antigen concentration tested (10 6 gametocyte/ml). 
Lymphocytes from gametocyte-immunised mice showed a strong in vitro 
proliferative response to ConA that peaked at 4 days of culture (Fig.4,a). The 
kinetics of proliferation were different from those observed with gametocytes, which 
peaked at 6-8 days (Fig.4,b). There is no proliferative response to uninfected RBC 
stimulation (Fig.4,c). In subsequent experiments, proliferative responses of spleen 
cells were observed after 4 days of stimulation. 
As shown in Table 2, gametocyte-immunised mice showed significantly higher 
proliferative responses to gametocyte stimulation than control mice. Some control 
mice also showed a positive lymphoproliferative responses to gametocytes. 
ConA induced a strong proliferative response in all mice. Uninfected RBCs did 
not induce proliferation. No significant difference was found in PHA and PPD 
responses between the gametocyte immunised and control PBS immunised group of 
mice. 
3.3.4 Cytokine production by immune lymphocytes in vitro 
To identify the profile of cytokines produced by immune splenic lymphocytes, 
cells were placed in culture for various time periods with stimulation with specific 
antigen, gametocyte, or the nonspecific stimulant ConA. The culture supernatants 
were collected and subsequently assayed for cytokines including IFN-y, IL-2, IL-4, 
IL-5, and IL- 10 by ELISA. Data of cytokine assays are shown in Fig.5. The titres of 
secreted cytokines were not significantly different between gametocyte-immunised 
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Figure 3. LymphoproliferatiVe responses to different doses of gametocyte antigen. 
The spleen cells from gametocyte-immunised mice responded to gametocyte 
stimulation in a dose-dependent manner. Data are expressed as mean ± S.E.(vertical 
bars present S.E.). 
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Figure 4. Kinetics of splenic lymphocyte proliferation to ConA (a), gametocytes 
(b), and uninfçcted RBC (c). Lymphocytes (1x10 5  cell/well) from gametocyte-
immunised and control mice stimulated with ConA (4ig/ml) or freeze/thawed 
extracts of gametocytes (10 6/ml) or RBC and cultured for 2, 4, 6, and 8 days. The 
data are represented as mean of stimulation index (S.I.) from three mice in each 
group. 



































Stimulation Index (S.I.) 
Media (CPM) ConA PPD 
PFIA 	Gametocyte RBC 
Control 	mice 
1 	(406) 30.3 2.5 
11.8 3.0 2.0 
1.2 
1 (614) 20.4 1.1 
2.6 1.4 
1.3 0.9 
1 	(3843) 5.4 1.3 
1.6 
1.0 




23.2 3.5 2.0 4.2 
0.7 





1 	(2072) 36.9 2.3 
5.8 







S.D. (1352) 10.5 1.0 
G ametocyte-immunised mice 





1 (1888) 10.5 	. 1.7 
3.4 
5.0 




11.9 1.2 2.3 3.7 
1.0 





1 (596) 21.7 1.4 
1.3 
3.3 




30.2 1.4 5.1 8.6 
1.0 







S.D. (827) 1.2.2 0.7 
Student's 	t-test 
0.64 1.14 0.28 3.74 -- t 
>0.5 >0.2 >03 0.002 -- 
P 
Table 	2. Proliferative 	responses 	of lymphocytes 
from gametocyte- 
immunised and PBS-immunised control mice to lysates of gametocytes and 
other antigens and rnitogens. Spleen cells from BALB/c mice were cultured 
for 4 	days with freeze/thawed extracts of 	
Flasinaditim iIcpanim 
gametocytes (10 6 /ml), uninfected RBC (105 /ml), 	
ConA 	(4i.tg/mi), PHA 
(5.tg/ml), and 	PPD (200U/ml). The incorporation 
of 	[H3 1 thymidine 
(1 .tCI / well) 	after 	an additional 18 h 
was measured and the mean 
Stimulation Index (S.I.) of triplicate cultures is shown. 
Figure 5. Cytokine responses of spleen lymphocytes cultured from BALB/c mice 
immunised with gametocyte/FCA or PBS/FCA. ELISA tests for IFN-gamma (a), 
IL-2 (b), IL-4 (c), IL-5 (d), and IL-10 (e) present in supernatant fluids of cells 
stimulated with ConA or gametocyte are shown; there is no obvious difference in 
cytokine production between these two groups. (The number represent the mice 
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mice and control mice (p>0.2 in all cases). A low level of I1L-4 secretion was 
observed in both groups. However, it was noticed that 2 mice immunised with 
gametocytes produced significant levels of IL-4. This was not seen in any of the 
control mice (Fig.5,c). Meanwhile, low levels of 11L-2 production after gametocyte 
challenge were observed in both groups. 
3.4 Discussion 
In this study, I have shown that specific anti-gametocyte humoral and cellular 
immune responses are generated in mice immunised with gametocytes. Antibodies 
against gamete antigens were generated in all BALB/c mice immunised with 
Plosmodiwnfalciparum gametocytes. The main gamete antigens recognised by the 
serum antibodies were the 230kD, 48/45 kD, 4OkD, and 27/25kD proteins, each of 
which have been previously shown to be targets of monoclonal antibodies which 
block infectivity of Plasmodium falciparwn to mosquitoes (Quakyi et al 1987, 
Rawlings and Kaslow 1992b, Rener et al 1983, Vermeulen et al 1985, Wizel et al 
1991). Previous studies in our laboratory (Begarnie, 1991) found that gamete-
immunised inbred mice produced variable antibody responses to gamete surface 
antigens, Pfs230 and Pfs48/45. But in the study where congenic mice received 
gamete immunisation (these gametes were further incubated for 5 hours to allow 
zygote formation, Good et al 1988), most strains were nonresponsive to either the 
230-kD or 48/45-kD antigens but responded well to the 25-kD zygote/ookinete 
antigen. Although there was some variation within strains, most of the variation was 
between strains. Data of my experiment indicate that BALBIC mice can be induced to 
give a strong and uniform antibody response to gamete surface antigen, Pfs230.This 
is different from previous studies. The most likely interpretation of these data is that 
the surface antigen expression is different from gametocyte, gamete to zygote. In 
P.falciparum, 230kD and 48/45kD proteins develop in gametocytes from 2-3 days 
all 
after the invasion of erythrocytes. After the terminal maturation to gametes, these. 
proteins are no longer synthesized but still retained for some time on the gamete 
surface (Kaushal and Carter 1984, Kumar and Carter 1984, Vermeulen et al 1986). 
The major antigenic change accompanying zygote formation is the appearance of 
25kD protein on its surface (Vermeulen et al 1985,Vermeulen et al 1986). Gametes 
mixed with zygote during the process of antigen purification could explain why 
immune mice produced antibodies against P1s25 but poor responses to P1s230 and 
Pfs48/45 in Good's experiment. 
Several studies regarding lymphoproliferative responses to sexual stage antigens 
in humans have been reported (Good et al 1987, Riley et al 1990). Previous studies 
revealed that there is a high frequency of gamete-reactive T cells in peripheral blood 
from nonexposed human donors (Good et al 1987). Another study revealed that 
gametocyte lysate elicited higher lympho- proliferation in malaria-immune donors 
than in non-immune donors (Riley et al 1990). These data imply that people exposed 
to malaria parasites can develop T cell-mediated immunity against gametocytes. In the 
studies presented here, spleen cells from gametocyte-immunised mice gave a stronger 
lymphoproliferative response than PBS-immunised mice under gametocyte 
stimulation. But there was no significant difference in ConA, PHA, or PPD 
responses between gametocyte-immunised and control mice. Thus Plasmodium 
falciparwn gametocytes can induce specific cellular immune responses in mice but 
do not affect non-specific immune response to other antigens or mitogens. 
Occasional proliferative responses to gametocyte antigen were seen in control mice. 
This may be an example of the spontaneous response in non-immune human donors 
reported by Good et al (1987). 
Cytokines produced by T cells play an important role in the induction and 
regulation of both cell-mediated and humoral immune responses. T helper cells have 
been divided into ThO, Thi, and Th2 subsets based on their function and cytokine 
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secretion patterns. Thi cells produce IL-2, IFN-y, and mediate DTH responses, 
whereas Th2 cells produce IL-4, 1L5, IL-6, IL-b, and induce B cell activation and 
differentiation. ThO cells produce all the above mentioned cytokines, as well as IL-3 
and GM-CSF(Mosmann and Coffman 1989, Sher and Coffman 1992, Street et al 
1990). Gametocyte-immunised mice showed a positive DTH response to gametocyte 
antigen suggesting that gametocyte antigens may stimulate the Thi subset of I cells, 
but in this study, there was no obvious stimulation of cytokine production. Some 
gametocyte-immunised mice produced IL-4 in response to ConA and gametocytes 
and low levels of IL-2 under gametocyte challenge suggesting that either Th2 or ThO 
cells were also capable of being activated in vitro. 
In conclusion, mice immunised with intra-erythrocytic gametocytes produced a 
uniform anti-gamete antibody response, in which IgGi was the predominant isotype. 
These mice also developed a strong DTh and lymphoproliferative response to 
gametocyte antigens; cytokine analysis suggestd that these cells may be of ThO or 
mixed Th11Th2 phenotype. 
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Chapter 4. PPD-treatment resulted in variable cellular and 
humoral immune responses in gametocyte-immunised mice 
4.1 Introduction 
Immunological recognition of target antigens of transmission-blocking immunity 
has been studied in several human populations. In all cases, about 40% of malaria-
exposed individuals do not make antibodies to the native Pfs230 molecule (Carter et 
al 1989a, Graves et al 1988, Premawansa et a! 1994, Riley et al 1994a), the major 
transmission-blocking target antigen on the surface of gametocytes/gametes. This 
non-responsiveness is stable over time and does not appear to be related to MHC or 
other genetic factors (Graves et al 1989, Riley et al 1994a). 
Malaria is a powerful activator of the immune system and the immunity is stage 
specific. Immunological events during primary exposure to an antigen are believed 
profoundly to influence the subsequent immune response (van der Pouw-Kraan 
1993). Therefore, the ongoing immune responses elicited by asexual stage parasites 
might affect the subsequent immune responses induced by sexual stage parasites. 
Limited antibody response to P1s230 may be due to the influence of primary 
exposure to asexual stage parasites. 
The use of an experimental model to study the apparently poor immunogenicity 
of gametocyte antigens may help in understanding the different factors influencing 
transmission-blocking immunity induced by gametocyte surface antigens. In this 
study we have attempted to establish a limited specific anti-gametocyte immunity 
mouse model similar to the limited immunogenicity observed in humans. BALB/c 
mice immunised with gametocyte-infected erythrocytes make a uniform antibody 
response to Pfs230 (Chapter 3). However, pretreatment of naive mice with PPD 
(purified protein derivative of Mycobacteriwn tuberculosis ) results in .a very variable 
antibody response to Pfs230. However, this antibody-depressive effect induced by 
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PPD We-treatment is a transient phenomenon; the capacity to produce anti-Pfs230 
antibodies is not affected in the long term. 
4.2 ExDeriment 
Experiment I - There are two groups of mice: The experimental group (n=8) 
received PPD-treatment followed by gametocyte immunisation and the control group 
(n=9) received PBS followed by gametocyte immunisation. Each of the mice in the 
experimental group was given two intraperitoneal injections of PPD 
(10,000U/mouse) 100d emulsified in an equal volume of FIA. The control group 
mice were immunised with PBS instead of PPD. The primary gametocyte 
immunisation with 3x106/mouse in FCA was on the 7th day after treatment of PPD 
or PBS. The second immunisation of 5x10 5 gametocyte/mouse in FIA was done 6 
weeks after primary immunisation. This schedule is summarised as follow: 
PPDIPBS 	PPD/PBS gametocyte 
	
first 	second 	first 
immunisation immunisation immunisation 
I----------------I--------------I------- 
day 0 	7 	14  
gametocyte 	 kill mice 
second 	 lymphoproliferation 
immunisation DTH 	cytokine assay 
I----------I-----------------I 
60 	64 	67 
serum 
collection 
Experiment II: The above experiment was repeated except that the immunised 
mice were kept for 6 months prior to a third gametocyte immunisation 
(2.5x 106/mouse in HA). There are 20 BALB/c mice in each group. This schedule is 
summarised as follow: 
ME 
PPDIPBS 	PPDIPBS gametocyte gametocyte 	gametocyte 
first 	second 	first 	second 	third 
mmunisation immunisation immunisation mmunisation 	immunisation 
I 	I 	I 	 I 	 I 
I---------------- I -------------- I ------------------- I -------- I----- II ------ I --------- I---> 
day 0 	7 	14 	60 70 	250 260 
serum collected on day 0, 70, 250,260 
4.3 Result 
Exoeriment I. PPD-treatment has an influence on the immune resnonses induced 
by subsequent gametocyte immunisation 
Variable levels of antibodies against gamete surface antigens as a result of 
pretreatment with PPD. To determine whether an ongoing immune response to an 
unrelated antigen influences the immune response to gametocytes, sera from mice 
immunised with PPD (with FIA) prior to gametocytes (with FCA) were tested for 
antibodies to gamete surface antigens. A comparison of the antibodies produced by 
mice which received PPD or PBS prior to gametocyte against gamete surface 
antigens is shown in Fig.6. Variable antibody responses to gamete surface antigens 
were found in mice which received PPD-treatment prior to gametocyte immunisation, 
while a uniform antibody response was induced in the control mice with only PBS-
treatment prior to gametocyte immunisation. Three mice in the experimental group 
produced strong antibody responses against Pfs230 and two were negative. 
Meanwhile, no anti-Pfs48/45 antibody was found in PPD-pretreated mice. Thus, 
PPD-pretreatment may influence the anti-gametocyte humoral immune response and 
result in variable antibody response to gamete surface antigens, Pfs230. 
Delayed-type hypersensitivity (DTH) responses to P.falciparum gametocytes 
Mice that had been immunised i.p. with PPD and P.falciparwn gametocytes were 
PPD/FIA-Gametocyte/FCA 	 PBSIFIA-GametocytelFCA 	MAb 
1 	2 	3 	4 	5 	6 	7 	8 	9 	10 11 12 13 14 15 16 
I .  Pfs JlIftr -230 205kD- 
I l6kD- 
9lkD- 	 111 
66kD- 
Mi 
4SkD- 	 I # 19 111 9  
29kD- 
II 	 1 _•uuI 
Figure -6 Recognition of 125 1 labelled Plasmodiurn falciparum gamete surface 
antigens by immune BALB/c scrum Serum samples were obtained from mice 
one week after the second immunisation with gametocytes. Autoradiograph of 
?I labelled gamete surface antigens immunoprecipitated with serum from PPD-
treated prior to gametocyte-immunised BALB/c mice and control mice. This 
autoradiography has been deliberately overexpressed so that any faint bands in the 
first 8 lanes would be visible. 
Lane 1-8: PPD treated mice; Lanes 9-16: control mice. Lane 17: Pfs23() specific 
monoclonal antibody (12F10). 
The double band present at 230-26OkD represents the processed and unprocessed 
forms of Pfs230. 
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tested for DTH responses to freeze/thawed gametocyte lysates. All control mice 
(given PBS with FIA prior to gametocyte with FCA i.p.) had a positive and uniform 
DTH reaction to gametocyte challenge. Mice given PPD prior to gametocyte 
immunisation showed very variable DTh responses (leading to a high value of 
standard deviation,S.D.) to gametocytes (Table 3). 
Proliferative response of lymphocytes Proliferative responses of spleen cells 
were observed after 4 days of stimulation. As shown in Table 4, mice which 
received PPD-treatment prior to gametocyte-immunisation showed significantly 
higher proliferative responses to PPD than did control mice. However, there is no 
difference in proliferative response to gametocyte stimulation between these two 
groups. 
Cytokine production by immune lymphocytes in vitro To identify the profile of 
cytokines produced by immune splenic lymphocytes, cells were placed in culture for 
various time periods (24, 48, and 72 hours) with stimulation with specific antigen, 
gametocyte, or the nonspecific stimulant ConA. The culture supernatants were 
collected and subsequently assayed for cytokines including IFN-y, IL-2, IL-4, IL-5, 
and IL- 10 by ELISA. Data of cytokines studies are shown in Fig.7. In general, the 
titres of lymphocyte-secreted cytokines were lower in PPD-treated mice than that in 
control mice, but the difference was not significant in statistics (p>0.05, Mann-
Whitney U-test). However, IFN-y levels were significantly lower in PPD-treated 
mice than in control mice (p=O.01 in ConA stimulation, Mann-Whitney U-test). 
Experiment II. Long-term study of the variable antibody response caused by 
PPD 
Variable levels of antibodies against gamete su,face antigens as a result of 
pretreatment with PPD. Individual serum samples were taken from mice 10 days 
after the second immunisation with the P.falciparwn gametocytes and were tested for 
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p=o.02 p<0. 0O 1 
Table 3. DTH response to gametocyte antigens in PPD pre-treatment and 
control mice. After immunisation, the DTH response was elicited by 
injection of 105 gametocytes into the right footpad and PBS only into the 
left footpad. Twenty-four hours later, the DTH response was determined 
by measuring the thickness of the footpad. Data are presented in unit 
of iO inch ± S.D. The difference between the thickness of the left and 











Medium ConA PPD Gametocyte RBC 
(CPM) (S.I.) (S.!.) (S.I.) (S.I.) 
13598 15.3 3.3 3.9 0.8 
1257 102.5 11.9 34.2 2.5 
9708 22.3 4.5 6.1 1.1 
6503 20.3 5.5 8.8 1.1 
826 187.7 13.4 33.4 3.2 
4368 47.9 5.4 11.1 0.7 
1799 98.7 14.2 19.2 1.1 
2520 59.1 10.4 12.7 0.9 
5072 69.2 8.6 16.2 1.4 
4575 58.6 4.4 11.8 0.9 
3576 41.4 2.6 9.7 1.1 
1309 96.8 2.8 28.6 1.3 
1828 61.4 3.1 17.1 2.2 
1427 98.4 3.6 26.0 2.9 
4559 22.8 1.3 4.4 1.5 
3520 38.5 1.8 8.5 1.0 
4301 26.3 1.3 7.9 2.2 
4449 32.1 2.2 9.2 1.9 
3121 52.2 2.3 13.9 1.8 







0.5 0.002 >0.5 0.2 
Table 4. Proliferative responses of lymphocytes from PPD pre-treated or 
PBS pre-treated, gametocyte-immunised mice to lysates of gametocytes 
and other antigens and mitogens. Spleen cells from BALB / c mice were 
cultured for 4 days with freeze/thawed extracts of Flasmodium 
i'Icpanim gametocytes (10 6 /ml), uninfected RBC (10 5/ml), ConA 
(4tg/ml), PHA (5tg/ml), or PPD (200U/ml). The incorporation of [11 3 ] 
thymidine (1tCi/well) after an additional 18 h was measured and the 
mean S.I. of triplicate cultures is shown. 
0 
Figure 7. Cytokine responses of spleen lymphocytes cultured from BALB/c mice 
immunised with PPD/FIA or PBS/HA prior to gametocyte/FCA. ELISA tests for 
IFN-gamma (a), IL-2 (b), IL-4 (c), IL-5 (d), and IL-10 (e) present in supernatant 
fluids of cells stimulated with ConA or gametocyte are shown; lower levels of 
cytokines produced in mice with PPD-pretreatment than that in PBS-pretreatment. 
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antibody to gamete surface antigens. The antigens recognised by the immune mouse 
serum were analysed by immunoprecipitation with gamete surface antigens. The 
profile of 1251  labelled antigens recognised by PPD-treated and PBS-treated mouse 
serum is shown in Fig.8. Sera from PBS-treated mice precipitated Pfs230, Pfs48145 
and Pfg27125. Sera from PPD-treated mice precipitated Pfg27125 but not Pfg48/45. 
10 of 16 mice sera precipitated Pfs230. These results are essentially the same as these 
obtained in Experiment I. Interesting, Pfg27125 was recognised by all mice; this is 
reminiscent of the situation in humans (Riley et a! 1994a). 
Serologic responses to Triton extract of P.falciparwn gametocytes. Individual 
serum samples were taken from mice 10 days after the second immunisation with the 
P.falciparuin gametocytes and were tested for antibody to gametocytes. Circulating 
serum antibodies to purified gametocyte protein (GP) were detectable by the ELISA 
(Fig.9,a). Specific anti-GP antibodies were found in both gametocyte-immunised 
groups, PPD-treated and PBS-treated mice, but antibody levels were significantly 
higher in PPD pre-treated mice than PBS treated mice (t-test, t=5.46, p<0.00 1). The 
IgG subclasses induced by the gametocytes were predominantly IgGi in both 
groups of mice (Fig.9,b). 
Serologic responses to PPD. 	Circulating serum antibodies to PPD were 
detectable by the ELISA (Fig.10,a). Anti-PPD antibodies were found in PPD-treated 
mice only. The IgG subclasses induced by the PPD were predominantly IgGi in 
PPD-treated mice(Fig. 10,b). 
The antibody-depressive effect induced by PPD-trealm ent is a transient 
phenomenon. Individual serum samples were taken from mice 10 days after the third 
immunisation with the P.falcipa rum gametocytes (8 months after the second PPD 
immunisation) and were tested for antibody to gamete surface antigens. The profile 
of 1 251 labelled antigens recognised by PPD-treated and PBS-treated mouse serum is 
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Figure-S Recognition of 1:51 labelled P1asnwdiun falciparu'n gamete surface 
antigens by immune BALB1c serum. Autoradiograph of 15J labelled zamctc 
surface antigens immunoprecipitated with serum from PPD-treatment prior to 
gametocyte-immunised BALB/c mice and control mice (ten days after the second 
gametocyte immunisation). 
1. Lines 1-8: PPD pretreated mice: lanes 9-16: control mice: lane 17: MAb 12F10 
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Figure 9. Specificity of anti-gametocyte antibody and pattern of IgG subclasses 
in sera. Serum samples were obtained from mice 10 days after immunisation with 
either PPD (n=19) or PBS (n=19) prior to two gametocyte immunisations. The 
immune sera were tested for anti-gametocyte specificity by ELISA using purified 
gametocyte protein (GP) as coating antigen. Specific anti-GP antibody was found 
in the immune sera from mice which received PPD or PBS prior to gametocyte 
immunisation.(a). The anti-GP antibodies were IgGi predominantly in immune 
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Figure 10. Specificity of anti-PPD antibody and pattern of IgG subclasses in 
sera. Serum samples were obtained from mice 10 days after immunisation with 
either PPD (n=19) or PBS (n=19) prior to two gametocyte immunisations. The 
immune sera were tested for anti-PPD specificity by ELISA using PPD as coating 
antigen. Specific anti-PPD antibody was found in the immune sera from mice 
received PPD prior to gametocyte immunisation (a). The anti-PPD antibodies were 
IgG 1 predominant in immune sera from PPD-pretreatment mice (b). Data are 
expressed as mean and S.E. 
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shown in Fig. 1 1. All PPD-treated mice produced anti-Pfs230 antibodies, including 
the seronegative mice tested 6 months ago. PBS-treated mice sera precipitated 
uniformly strong bands at 230kD. These results suggest that the influence induced by 
PPD-treatment could not be permanent. 
4.4 Discussion 
In this study, the effect of PPD on humoral and cellular immune responses to 
gametocyte was analysed. All the data are summarised in Table 5. It is clear that both 
antibody and cellular immune responses are more variable in the PPD-treated mice 
than the PBS-treated mice. However, it is different to discern any obvious pattern to 
this variability. DTh and proliferative responses to gametocyte antigens appear to be 
dissociated in PPD-treated mice; antibody negative mice tend to be DTH-positive but 
the numbers are too small to draw any firm conclusions. These experiments would 
need to be repeated in much larger group of mice to determine any real pattern. 
The strong lymphoproliferative responses to PPD indicates that PPD induces a 
specific immune response during the period of development of gametocyte-specific 
immunity. Variable specific antibody and DTH responses could be due to the 
interaction between PPD and gametocyte antigens.These observations may be 
considered as a model for the limited gametocyte-specific immune response seen in 
human populations, and could be useful for the investigation of this immunological 
restriction. 
The variable antibody response to gamete antigens, Pfs230, induced by PPD 
pre-treatment is transient and the capacity to give a secondary response is unaffected 
in the long term. Antigenic competition between PPD and gamete surface antigens 
might be the possible explanation for this phenomenon. A previous study found that 
a prior injection of sheep red blood cells (SRBC) resulted in subsequent horse red 












Figure-11 Recognition of -I labelled Piasmodiwn JaIei/)aru/n gamete surface 
antigens by immune BALB/c serum. Autoradiograph of 1251  labelled gamete surface 
antigens immunoprecipitated with serum from PPD-treatment prior to gametocyte-
immunised BALB/c mice and control mice (ten days after the third gametocyte 
immunisation). 
PPD pre-treated mice. 
PBS pre-treated mice. 
* represents that the mouse was scronegative SR months ago ( l() days after the 
second gatheR )c\tcs i mimi n isati()n). 
P1g271 
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*øe. I.6 so) & a. 
Humoral immune responses 	 Cellular immune responses 
Anti- 	Anti- 	Anti- 	 DTI-1 	Prolife 	IFN- 	IL-2 	IL-4 IL-5 	IL-10 
GPAb 	230kD 48/45 ration- 	gamma 
kD 	 garnet. 
PPD- 
treated 
1 	+ 	+ 	- 	 ++ 	- 	+ 	+ 	+ + 	+ 
2 + +++ - - +++ + + + + - 
3 	+ 	++ 	 + 	+ 	+ 	+ + 	+ 
4 - - - 	 + 	± + + + + + 
5 	+ 	++ 	- - +--i- 	+ 	+ 	- + 	- 
6 + ++ - 	 - 	+ + + - + + 
7 	+ 	+1-- 	- + + 	+ 	+ 	- + 	- 
8 - - - 	 ++ 	+ + + - + - 
PBS- 
treated 
1 	+ 	++ 	+ 	 ++ 	+ 	+ 	+ 	+ + 	- 
2 + + + + ++ + + + + + 
3 	+ 	++ 	+ 	 + 	+ 	+ 	+ 	+ + 	- 
4 + ± + + ++ + + + + - 
5 	+ 	+ 	+ 	 + 	- 	+ 	+ 	+ + 	+ 
6 + + + - + + + + + + 
7 	+ 	+ 	+ 	 + 	+ 	+ 	+ 	+ + 	+ 
8 + + + + + + + + + + 
Table 5. Summary of the humoral and cellular immune responses of PPD-treated and 
PBS-treated gametocyte-immunised BALB/c mice. 
Data of anti-GP antibodies are values of O.D. by ELISA. Number of "+" refers to the 
levels of response, compare with the mean value of control group (PBS-treated mice). 
Pfs230-immunoprecipitation refer to intensity of bands on autoradiography, compared 
with MAb standard. 
In gametocyte-specific DTH and proliferative responses, number of 	refers to the 
levels of response, compare with the mean value of control group (PBS-treated mice). 
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1971). This temporary antibody-depression is T cell-dependent. Another example of 
immunologic interference is Coiynebacteriwn parvwn preimmunisation which caused 
suppression of the primary antibody response to SRBC (Ansell et al 1983). This 
immunosuppressive response was a spleen-localised and transient phenomenon. 
Thus, in my study, seronegativity could be due to antigenic competition and this 
suppressive effect may not be permanent. 
However the limited antibody response to Pfs230 in humans is stable over time 
in malaria-endemic regions (Riley et al 1994). This phenomenon is different from the 
mouse model presented in this study. However, people living in malaria endemic 
areas receive asexual parasites continuously via mosquitoes biting, ie. exposure to 
gametocytes is always preceded by exposure to asexual stage malaria parasites. 
Therefore, it may be necessary to boost with PPD in order to maintain the 
immunologic interference to the subsequent gametocyte antigens. Further 
experiments are needed to test this hypothesis. 
Chapter 5. 	Immunological status induced by PPD- 
pretreatment 
5.1 Introduction 
In view of the results presented in the previous chapters, further studies were 
made on the ongoing immune response induced by PPD. Normal healthy human 
peripheral blood mononuclear cells (PBMCs) cultured with PPD produce mainly 
IFN-y producing cells and very few IL-4 producing cells (ElGhazali et al 1993). 
Meanwhile, studies by Pearlman et al have indicated that mice immunised with PPD 
produced IFN-y, but not IL-4 or IL-5 (Pearlman et al 1993). These results suggest 
that PPD induces a predominantly Thi-type immune response. 
To determine a possible reason for the effects of PPD on antibody responses to 
Pfs230, specific cellular and humoral immune responses to PPD were assayed. 
5.2 Exueriment 
Experiment I: Each of the mice in the experimental group (n=1 1) was given two 
intraperitoneal injection of PPD (10,000U/ml) 100 pil emulsified in an equal volume 
of Freund's Incomplete Adjuvant (FIA). Control mice (n=10) were immunised with 
PBS instead of PPD. The schedule is summarised as follow: 
kill mice 
primary 	 second 	 lymphoproliferation 
immunisation 
	
immunisation 	 DTH 	cytokine assay 
I 	 I 	 I 
I------ I -----------------I-----I----- I ------------------------- I-- 
dayO 1 	678 	 14 
	
20 
Serum collected on day 0, 1, 6, 8, 20. 
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5.3 Result 
Analysis of antibodies produced in mice immunised with PPDIFIA or PBS/FIA. 
Individual serum samples were taken from mice after immunisation with the 
PPD/FIA or PBSIFIA and were tested for antibody to PPD. Circulating serum 
antibodies to PPD were detectable by ELISA (Fig. 12,a). PPD-immunised mice make 
a specific antibody response. In contrast, mice which received PBSIIFA do not 
produce anti-PPD antibody. The IgG subclass induced by the PPD in mice 
immunised with PPD was predominantly IgGi (Fig. 12,b). 
Delayed-type hypersensitivity (DTH) responses to PPD Mice that had been 
immunised i.p. with PPD or PBS were tested for DTH responses to PPD. All mice 
given PPD with WA had a positive and uniform DTH reaction to PPD challenge. 
Control mice given the PBS with WA did not make DTH responses to PPD (Table 
6). 
Proliferative response of lymphocytes Proliferative responses of spleen cells 
were observed after 4 days of stimulation. As shown in Table 7, PPD-immunised 
mice showed significantly higher proliferative responses to PPD stimulation than 
control PBS-immunised mice. Meanwhile, LPS and PHA stimulation resulted in 
higher levels of proliferative responses in PPD-immunised mice than in mice which 
received PBS immunisation. 
Cytokine production by immune lymphocytes in vitro. To identify the profile of 
cytokines produced by immune splenic lymphocytes, cells were placed in culture for 
three days with stimulation with ConA or PPD. The culture supernatants were 
collected and subsequently assayed for cytokines including IFN-y, IL-2, IL-4, IL-5, 
and IL-10 by ELISA. Data of cytokines studies are shown in Fig. 13. The titres of 
Figure 12. Specificity of anti-PPD antibody and pattern of IgG subclasses in sera. 
Serum samples were obtained from mice two weeks after immunisation with either 
PPD or PBS. The immune sera were tested for anti-PPD specificity by ELISA using 
PPD as coating antigen. Specific anti-PPD antibody was found in the sera from mice 
which received PPD immunisation (a). The anti-PPD antibodies were predominantly 



































n 	t 	p 
11 	2.99 	<0.01 
10 	0.24 	>0.5 
Table 6. DTH response to PPD in PPD/ FIA-immunised and control mice. 
After immunisation, the DTH response was elicited by injection of 100U 
PPD into the right footpad and PBS only into the left footpad. Twenty-
four hours later, the DTH response was determined by measuring the 
thickness of the footpad. Data are presented in unit of 10 inch ± S.D. 
2 
Medium ConA LPS PHA PPD 
(CPM) (S.I.) (S.I.) (S.I.) (S.I.) 
PBS- 
immunised 
831 78.2 5.6 4.4 3.2 
946 56.4 7.5 8.8 1.7 
1369 33.0 2.9 5.9 1.9 
1094 52.1 3.5 4.7 1.6 
1532 50.0 4.4 5.5 1.8 
1312 24.3 4.2 3.1 1.6 
2474 30.5 5.5 7.5 1.9 
1458 28.7 4.7 5.5 1.8 
1055 55.7 5.2 6.5 1.5 
1274 63.5 5.3 6.5 2.1 
Mean 1335 47.2 4.9 5.8 1.9 
S.D. 459 17.5 1.3 1.6 0.5 
PPD- 
immunised 
1538 44.2 9.7 7.1 6.1 
779 81.8 4.6 9.7 5.4 
932 77.2 1.9 9.9 3.1 
1353 41.0 9.3 7.6 7.9 
1926 34.5 7.7 7.8 5.8 
1207 41.5 10.1 6.5 4.5 
1953 34.1 7.0 5.3 3.1 
1436 41.5 8.9 8.0 3.5 
1155 55.5 6.1 6.0 3.3 
1011 59.4 7.1 7.4 6.3 
1930 25.4 5.2 6.2 3.4 
Mean 1384 48.7 7.1 7.4 4.8 
S.D. 417 17.9 2.5 1.4 1.6 
Student 
t-test 
t 0.19 2.48 2.35 4.41 
P >0.5 0.02 0.02 <0.01 
Table 7. Proliferative responses of lymphocytes from PPD/IFA and PBS/IFA 
immunised mice to PPD and other mitogens. Spleen cells from BALB/c mice were 
cultured for 4 days with ConA (4igIml), LPS (10igIm1), PHA (5tg/ml), and PPD 
(200U/ml). The incorporation of [I-P] thymidine (1pCi/well) after an additional 18h 
was measured. 
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Figure 13. Cytokine responses of spleen lymphocytes cultured from BALB/c 
mice immunised with PPD/HA or PBS/HA ELISA tests for IFN-gamma (a), 
IL-2 (b), IL-4 (c), IL-5 (d), and IL-10 (e) present in supernatant fluids of cells 
stimulated with ConA or PPD are shown; lower levels of cytokines produced in 
mice with PPD/FIA immunisation than that in PBS/IFA immunisation. (The 
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lymphocyte-secreted IL-2 and IL-4 from ConA stimulation were higher in PBS mice 
than in mice immunised with PPD (p<0.05 in IL-2 and p<z0.02 in IL-4). 
5.4 Discussion 
These studies have examined functional properties of PPD as measured by it's 
ability to induce DTH reactions and lymphoproliferative responses as well as specific 
antibody and cytokine production. BALB/c mice immunised with PPD develop DTH 
response, high levels of lymphoproliferation and specific anti-PPD antibodies. In 
contrast to the above immune responses, cytokine secretion in PPD-immunised mice 
are lower than in control (PBSIFIA-immune) mice. The striking difference is the high 
levels of I1--2 and IL-4 production in mice which received PBS. Although we could 
not confirm the findings of Pearlman et al (1993) and ElGhazali et al (1993) that PPD 
stimulates cells to develop a Thl phenotype, we were able to show that cells from 
PPD-immunised mice produced low IL-4 than control mice. This suggests that Th2 
cells may be down-regulated in PPD-immunised mice. Further experiments, 
including optimization of the immunisation protocol, could be needed to confirm 
these findings. 
The results from this experiment show that the PPD immunisation protocol 
induces a strong anti-PPD response, which may be sufficient to interfere with the 
response to subsequent gametocyte immunisation. If PPD-mediated down-regulation 
of Th2 cells can be confirmed (even if in only some immunised mice) it may explain 
the suppression of the antibody response. 
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Chapter 6. Gametocyte induced immune response in 
malaria-infected mice 
6.1 Introduction 
It has been shown previously that ongoing Th responses induced by parasite 
infection can influence the Th response to an unrelated antigen. For example, 
infection with Schistosoina inansoni induced a down-regulation of Thi responses 
and elevation of Th2 response to unrelated foreign immunogens (Kullberg et al, 
1992). The major protective immune mechanisms to blood stage malaria are T cell-
dependent. In P.chabaudi infection, CD4 T cells control acute primary parasitemia 
by mechanisms which appear to be predominantly antibody-independent, but these 
early responses are superseded by antibody-mediated immunity which finally clears 
the parasites from the blood (Langhorne, 1989).These observations led us to wonder 
whether the specific immune status induced by primary exposure to the malaria 
asexual stages may affect the subsequent immune response to sexual stage antigens. 
It has been clearly demonstrated in my previous studies that an ongoing 
immune response induced by PPD can modulate the subsequent immune response 
induced by unrelated gametocyte antigens. Further research will concentrate on 
immune modulation by primary infection with parasites. In order to investigate 
whether asexual malaria infection influences the subsequent gametocyte-specific 
immune response, we used the P.chabaudi ada,ni murine malaria model. Previous 
studies of this infection revealed that T cells are crucial for the resolution of acute 
infection, although antibodies are necessary for complete elimination of parasites 
(Grun and Weidanz, 1981). We wanted to investigate whether the T cell responses 
induced by P.chabaudi adaini infection can influence the subsequent immune 
response to gametocyte antigens. In mice which received P.chabaudi adami infection 
prior to P.falciparu,n gametocyte immunisation, the gametocyte antigens will induce 
immune responses in the presence of a P.chabaudi adami specific T cell-mediated 
immune status. Cellular and humoral immune responses are assayed to understand 
the effect of primary infection with malaria on the immunogenicity of gametocyte 
antigens. 
6.2 Experiment 
Three groups of mice were used-- P.chabaudi adami infection prior to 
P.falciparuin gametocyte immunisation (group PcIPf, n=15), P.chabaudi infection 
only (group Pc/o, n=14), and P.falciparwn gametocyte immunisation only (group 
oIPf, n=14). Mice were given i.p. injections of 1x10 6 Plasmodium chabaudi adami 
parasites. Each of the mice in group PcIPf and o/Pf was given two intraperitoneal 
injection of gametocyte (3x10 6/mouse in FCA and 5x105/mouse in FIA). The 






PcIPf: P.chabaudi adami gametocytelFCA 	gametocyte/FIA kill 
infection 	immunisation 	 immunisation 
oIPf: 	 gametocyte/FCA 	gametocyte/FIA kill 
immunisation 	 immunisation 
Pc/o : P.chabaudi adami 	 kill 
infection 
6.3 Result 
6.3.1 Plasmodium chabaudi adami parasitemia 
Mice in group Pc/Pf and Pc/o were infected with Plasinodium chabaudi adami 
and the parasitemia was measured to assess the course of infection. Parasitemia 
reached peak on day 7 after infection then declined to a very low level after two 
weeks. Infected mice kept this low level of parasitemia during the period of 
gametocyte immunisation (Fig. 14). (Mice were not treated to remove parasites). 
6.3.2 Effect of asexual parasitemia on the antibody response to gametocyte 
antigens 
Individual serum samples were taken from mice 7 days after the second 
immunisation with the P.fakipa rum gametocytes and were tested for antibody to 
gamete surface antigens. The antigens recognised by the immune mouse serum were 
analysed by immunoprecipitation with gamete surface antigens. The profile of 1 251 
labelled antigens recognised by immune and control mouse serum is shown in 
Fig. 15. As expected, mice which received only gametocytes produced a strong and 
uniform antibody response to Pfs230, Pfs48145 and Pfg27/25 (Fig.15b). The 
response to the 4OkD antigen was somewhat variable. Mice infected with P.chabaudi 
adami , but not immunised with gametocytes, produced very little anti-gamete 
antibody. Faint bands were see for some sera suggesting that there may be a degree 
of cross-reactivity between the two Plasmodium species (Fig 15c). In mice which 
were infected with P.chabaudi adami and then immunised with gametocytes, the 
response to Pfs230 was uniformly strong in all mice (Fig. 15b). However, antibody 
responses to Pfs48/45 and Pfg27/25 did vary. 
6.3.3 Proliferative response of lymphocytes 
Proliferative responses of spleen cells were observed in a subset of the 
immunised mice after 4 days of stimulation. As shown in Table 8, mice which 
received P.chabaudi adami infection prior to P.falcipanim gametocyte immunisation 
showed significantly lower proliferative responses to PHA and gametocyte 
stimulation than did control mice, which received gametocyte immunisation only or 
parasites infection only. However, strangely, the response to gametocyte stimulation 
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Fig 1 4.Parasitemia in BA LB/c mice infected with P.chabaudi adami (n=29). 
Data are presented as mean and S.D. 


















Figure- 15 Recognition of 1251  labelled Plasmodiurn falciparutn gamete surface 
antigens by immune BALB/c serum. Autoradiograph of 1251  labelled gamete 
surface antigens immunoprccipitatcd with serum from mice with (a)P.chabaudi 
adami infection prior to P.ftilciparum gametocytes immunisation, (b)P.ftulciparwn 
gamctocytcs immunisation, and (c)P.chabaudi adami infection. (a) PcIPf, (b) 
oiPI, (c) Pcio. 
The strong bands at approx 100-1 IOkD probably represent degraded Pfs230. 
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Table 8. Proliferative responses of lymphocytes from mice with 
P.chabaudi 
adaini infection prior to P.falciparum gametocytc-immunisation and control mice 
to lysates of gametocytes and other mitogens. Spleen cells from BALB/c mice 
were cultured for 4 days with freeze/thawed extracts of Plasmodium falciparuin 
gametocytc (106/ml), uninfected RBC (1051m1), ConA (4igJm1), PHA 
(59gIml), 
and PPD (200U/ml). The incorporation of IH 3 1 thymidine (ltCi/wcll) after an 
additional 18 h was measured. 
(1 
Medium ConA PHA LPS PPD (Jameto. RBC 
(CPM) (S. I.) (S. I.) (S. I.) (S. I.) (S. I.) (S. I.) 
Pc/Pf 
2820 10.4 1.9 3.2 1.1 2.6 1.0 
2025 12.0 2.4 4.0 1.4 2.2 1.8 
944 3.2 1.0 4.9 0.9 0.8 3.9 
1609 27.3 3.6 6.6 1.2 2.9 1.7 
2496 14.3 2.0 4.1 1.1 3.3 1.7 
5096 9.1 3.8 3.7 1.1 2.9 1.1 
4920 5.9 2.9 1.0 0.6 1.1 0.7 
Mean 2844 11.7 2.5 3.9 1.1 2.3 1.7 
S. D. 1597 7.8 1.0 1.7 0.3 1.0 1.0 
o/Pf 
785 9.7 2.0 4.0 1.3 3.2 1.5 
2356 11.7 1.6 3.5 1.1 5.1 1.7 
2593 18.4 5.7 5.7 1.4 4.1 2.0 
2101 22.0 5.7 7.4 2.4 7.7 1.9 
2689 13.2 3.9 2.9 1.9 2.4 2.1 
2745 20.2 7.7 6.2 2.5 2.1 2.4 
2413 29.5 9.1 6.9 2.2 6.6 3.2 
Mean 2241 17.8 5.1 5.2 1.8 4.4 2.1 
S. D. 678 6.9 2.8 1.8 0.6 2.1 0.6 
Pc/o 
3186 5.6 1.9 2.0 0.5 3.8 1.1 
1238 35.2 12.2 8.9 1.5 12.7 2.2 
550 2.7 4.4 4.9 1.7 5.4 1.5 
881 2.5 1.8 3.0 0.9 1.2 1.5 
864 30.7 10.6 7.1 2.0 18.6 2.8 
598 9.9 3.5 7.3 2.6 9.6 1.6 
2681 23.6 10.2 5.6 1.0 7.3 1.5 
Mean 1428 15.7 6.4 5.5 1.4 8.4 1.7 
S. D. 1062 13.8 4.4 2.4 0.7 5.9 0.6 
PcIPf- t 1.56 2.30 1.40 260 2.50 0.90 
o/Pf p >0.1 <0.05 0.2 0.02 <0.05 >0.2 
Pc/Pf- t 0.7 2.3 1.4 1.1 27 
Pc/o p 0.5 <0.05 0.2 >0.1 0.02 
oIPf- t 0.36 0.66 0.27 1.08 1.72 1.26 
PcIo p >0.5 >0.5 >0.5 >0.2 >0.1 >0.2 
Pc/PI: F chabaudiizduni infection prior to FfaIc.p.cirum gametocyte immunisation 
ofPf: Fhzlcipaivm gametocyte immunisation only 
Pc/o: Rthabauthadmii infection only 
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6.3.4 Cytokine production by immune lymphocytes in vitro 
To identify the profile of cytokines produced by immune spleen lymphocytes, cells 
were placed in culture for various time periods with stimulation with the stimulant 
ConA. The culture supernatants were collected and subsequently assayed for 
cytokines including IFN-y, IL-2, IL-4, and IL-5 by ELISA. Data of cytokines 
studies are shown in Fig. 1 6.The titres of lymphocyte-secreted cytokines were not 
significantly different among these three groups (p>=0.2), but there was a 
suggestion that both IL-4 and IL-5 may be lower in mice which were infected with 
P.chabaudi adarni than in mice that received only gametocytes. 
6.4 Discussion 
The immunological condition induced by primary exposure to an antigen can 
influence the subsequent immune response (van der Pouw-Kraan et al 1993). 
Pearlman et at found that the response to PPD can switch from Thi-type to Th2-type 
when an ongoing Th2-type immune status has been induced by primary exposure to 
Brugia nialayi antigen (Pearlman et a! 1993). Furthermore, infection with 
Schisrosoma mansoni induced elevation of Th2 responses to unrelated foreign 
immunogens as well as to parasite antigens themselves (Kullberg et al, 1992). In this 
study, mice infected with P.chabaudi ada,ni prior to gametocyte immunisation are 
taken as a similar model of the process of malaria infection. The main purpose is to 
examine whether the immune response induced by asexual parasites during infection 
can influence the subsequent gametocyte-induced immune responses. 
In this study, the effect of P.chabaudi adarni infection on humoral and cellular 
immune responses to gametocyte was analysed (Table 9). Uniform antibodies against 
gamete surface antigens are found in both gametocyte-immunised groups mice (Pc/Pf 
and oIPf). There is no significant difference in gamete-specific antibody response 
between these two groups. In contrast to this, P.chabaudi adwni infection alone does 
not induce a significant antibody response against gamete surface antigens. The most 
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Figure 16. Cytokinc responses of spleen lymphocytes cultured from BALB/c 
mice infected with P.chabaudi adarni prior to P.falciparum gametocyte 
immunisation. Mice received P.chabaudi adami infection or P.falciparum 
gametocyte immunisation are taken as control. ELISA tests for IFN-gamma (a), 
IL-2 (b), IL-4 (c), and IL-5 (d) present in supernatant fluids of cells stimulated 
with ConA are shown; there is no obvious difference in cytokine production 
among these three groups. (The numbers represent the mice that did not produce 
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Table  9. Summary of the humoral and cellular immune responses of BALB/c mice with P.chabaudj adami 
(Pc/Pt), P.falciparu,n 
infection prior to P.falciparum gametocytes immunisation 
gametocyte 
infection only (Pc/o). 
immunisation only (o/Pf), and P.chabaudj adarni 
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interesting difference among these three groups is the gametocyte-specific 
proliferative responses; lower gametocyte specific lymphoproliferative responses 
were found in P.chabaudi adami infected mice which received gametocyte 
immunisation, compared with the controls (gametocyte-immune and P.chabaudi 
adwni-infected mice). The effect of asexual malaria parasitemia on the subsequent 
response to gametocytes was not as marked as we had expected. The effect was 
much more subtle than the effect of PPD immunisation. However, the differences in 
T cell proliferation between the 3 groups suggest that there may be some immune 
modulation occuring as a result of P.chabaudi adwni infection. Further experiments, 
altering the timing of the gametocyte immunisation in relation to the levels of asexual 
parasitemia, may produce were clear cut results. Immunosuppression has been 
observed in rodent malaria. Greenwood found that immunisation with SRBC during 
P.berghei yoelii infection resulted in suppression of the response to SRBC. The 
maximal degree of immunosuppression coincided with the peak of parasitaemia 
(Greenwood et al 1971). In the present study, infected mice received gametocyte 
immunisation at low parasitaemia (two weeks after infection). It is possible that 
gametocyte immunisation at peak parasitemia would have shown more suppression 
of the gametocyte-specific response. 
It is well recognized that diverse immune responses in the same strain of mouse 
are due to activation of different CD4 T cell subsets. Th 1 cells render cell-mediated 
immunity and Th2 cells promote antibody response. Further studies of the activation 
of T helper cell subsets may provide evidence to resolve the question of 
nonresponsiveness to gametocyte antigens. 
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Chapter 7 General Discussion 
The experiments described in this report demonstrate that, in mice, the ongoing 
immune response induced by primary exposure to an antigen such as PPD or asexual 
malaria infection (P.chahaudi adami ) can influence the immune response to 
P.falciparwn gametocyte antigens. These observations suggest that the restricted 
immunogenicity of Plasmodiumfalciparwn sexual stage parasites may be the result 
of immunomodulation by responses induced by asexual stage parasites or an 
unrelated antigen. This mouse model for limited immune response to P.falciparurn 
sexual stage parasite antigen would be a useful tool to study the apparently poor 
immunogenicity of certain malaria sexual stage antigens. 
Plasmodiumfalciparuin gametocyte-immunized BALB/c mice develop a strong 
and uniform antibody response against gamete surface antigens. PPD-treatment prior 
to gametocyte immunization results in a variable antibody response to the gamete 
surface antigens Pfs230 and Pfs48/45, some mice do not generate antibody against 
these gamete surface antigen while the others produce variable antibody responses. 
Interestingly, antibodies to the soluble internal antigen Pfg27/25 are less affected than 
the response to the membrane-associated antigens Pfs230 and Pfs48/45. This 
suggests that the immunological competition may be affected by the physical 
characteristics of the antigen. 
Immunological events during primary exposure to an antigen are believed 
profoundly to influence the subsequent immune response. Pearlman and colleagues 
described the establishment of a Th 2 immune response before induction of immune 
response to PPD, resulting in deviation of the latter to the Th 2 subset by an LL-4-
dependent mechanism (Pearlman et al 1993). The results of the present study 
indicated that PPD pretreatment affects the gametocyte-induced immune response. It 
is possible that PPD -immunisation resulted in down-regulation of Th2 responses 
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rather than stimulation of typical Thi type immune responses. Subsequent 
gametocyte immunisation resulted in variable antibody responses -- this might be 
due to down-regulation of Th2 cells. 
It has been suggested that malaria antigens can induce an immunosuppressive 
effect in both the mouse and human (Greenwood et al 1971, MacDermott et al 1980, 
Nussenzweig 1982, Weidanz 1982, Srour et al 1988, Riley et al 1989). Leichuk 
reported that malaria-induced immunosuppression decreased IL-2 production but not 
IL-i (Leichuk et al 1984). In our studies, depression of proliferative responses were 
found in P.chabaudi adami infected mice subsequently immunised with 
gametocytes. These results imply that some malaria-exposed individuals may develop 
an immunosuppressive condition created by blood-stage malaria parasites.It has been 
reported that acute blood stage malaria infection results in suppression of antibody 
responses to the sporozoite stage (Orjih et al 1979). 
The results of this present study raised the question - whether the suppressive 
effect of PPD-treatment is permanent. The long term study of the anti-gamete 
antibody response in mice treated with PPD reveals that this immunologic 
interference is a transient phenomenon. PPD-treated mice which were re-immunised 
with gametocytes 8 months later, made a uniform antibody response against gamete 
surface antigens.This phenomenon is different from the observation seen in humans. 
The seronegative phenotype in malaria endemic regions is stable over time (Riley et 
al, 1994a). It is possible that malaria asexual stage parasites produce a long lasting 
influence on the sexual stage parasites which is different from the temporary effect of 
PPD. Another possible explanation is that the permanent influence in humans is the 
result of continuous infections with asexual parasites in malaria endemic regions.This 
suggests that continuous boosting with PPD could result in a long term immunologic 
interference on gametocyte-specific immunity. 
77 
Plasmodium chabaudi adwni infection prior to gametocyte immunisation did not 
cause such a variable antibody response to gametocyte/gamete surface antigens as 
seen with PPD, but did induce depression in the proliferative response to 
gametocytes. On the other hand, variable gametocyte-specific proliferative response 
were found in parasite-infected mice. This may indicate immunologic interference in 
cellular immune responses which differs from the influence of PPD on humoral 
immunity. From these results, I suggest that the ongoing immune response (induced 
by prior to immunisation with an unrelated antigen or by concomitant asexual malaria 
parasitemia) can influence the immune response to sexual stage antigens. 
In response to infection, the host invokes the appropriate effector functions. But 
not all of the immune mechanisms are effective against a particular pathogen. Parasite 
infection results in complicated immune responses due to different antigens being 
expressed on different developmental stages in life cycle. Moreover, the different 
developmental stages in a complex life cycle are unlikely to evoke identical immune 
responses. The Th2 immune response in murine schistosomiasis is stimulated by 
eggs and not by the preceding schistosomula and adult worm stages (Pearce et al 
1991). Recent studies find that diverse immune responses are evoked by different 
developmental stages in filarial parasite infection, larval microfilariae induce Thl 
response but adult worm infection results in a Th2 response. The polarization of the 
immune response in a Th2-like direction by adult filarial parasites may be modulated 
by the larval microfilariae (Lawrence et al 1994). These observations, and results 
from my experiments, suggest that the immune responses induced by each 
developmental stage in the life cycle of a parasite could influence each other, 
especially the preceding immune response could modulate the immunity of 
subsequent developmental stage parasite. The net effect of such interactions may be 
to inhibit the development of optimally protective immunity to the parasite. Such 
interactions may explain not only the limited immunogenicity of certain specific 
antigens, but also the failure to develop protective immunity after primary or 
secondary infections. The net outcome is that parasitic infections tend to be long and 
chronic, with the host mounting varied and unsuccessful immunologic responses 
(Cox et a! 1992). 
In conclusion, the studies presented in this thesis provide evidence that some 
forms of antigenic competition may be responsible for the apparently poor 
immunogenicity of some malaria antigens. I have studied the T cell response to 
gamete antigens in mice subjected to a variety of immuno-modulatory procedures. 
There is clear evidence that the antibody response to gamete surface proteins can be 
manipulated by prior exposure to a strong, but unrelated, immunogen. 
Unfortunately, I was not able to come to any firm conclusions regarding the 
mechanisms involved in this immuno-modulation. Further experiments are needed to 
clarify this situation. Such experiments may provide information of great importance 
for the development, and administration of effective malaria vaccines. 
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Appendix I: Recipes -- 
1.Gametogenesis stimulating medium! Mosquito exflagellation factor (GSMJMEF) 
50-100 pupae of any Anophelene mosquito species are rinsed in dH20 and added 
to 20m1 of complete RPM! medium. The suspension of pupae is homogenised with 
a teflon pestle and centrifuged at 20,000g for 10 minutes at 4°C. Carefully remove 
the clear supernatant from beneath the fatty layer and filter through a 0.22tm filter. 
Adjust the filtered extract to pH8.7 and use at room temperature. 
IODOGEN (1 3..4.6-tetrachloro-3a.6a-diphenylglvcoluril) 
1mg of LODOGEN powder is dissolved in 2ml chloroform. The solution is 
dispensed in 50d amounts into 1.5 ml microcentrifuge tubes and swirled in the tube 
under a gentle air stream to evaporate to dryness. The IODOGEN-treated tubes can 





0.5% Triton X-100 






0.5% Triton X-100 
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0.0 1% NaN3 
pH 7.4 
NETTI 
Protease inhibitors (Sigma) are added to NETT from the following stock solutions 
each at 100X concentration: 
lodoacetamide -- 20mg/mi in H20 
N-Tosyl-L-phenylalanine chioromethyl ketone (TPCK) -- 7mg/ml in DMSO 
1.1 0-Phenanthroline (o-Phenanthroline) (OPT) -- 20mg/mi in EtOH 
0-Phenylenediamine (OPD) -- 20mg/mi in H20 
Phenyimethyl suiphonyl fluoride (PMSF) -- 40mg/mi in Propanol 
Sample Buffer (S B) 
2X non-reducing SB: 125mM Tris, 10% SDS, 20% glycerol, 0.002% 
bromophenol blue, pH 6.8 
2X reducing SB: inaddition to the above, 10% -mercaptoethanol 
Protein A-sepharose CL.4B bead suspension 
Protein A-sepharose dry beads were suspended in NETT to give a 25% v/v bead 
suspension, the suspension was stored at 4°C. The suspension was shaken prior and 
during use. 
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Appendix II: Standard curves of cytokines and IgG subclass ELISA's 
Cytokine ELISA's 
Representative standard curves for IFN-y, IL-2, IL-4, IL-5 and IL- 10 are shown 
on the following pages.Data were collected using the ELISALITE data analysis 
package (Dynatech, UK) and the line of best fit was drawn. The working range for 
each assay is shown. 
IgG subclass quantitication: 
Representative standard curves for IgG 1, IgG2a, IgG2b and lgG3 are shown. 
There were also produced using the ELISALITE programe. The working range for 
an assay was from 15.6-2000ig IgG/ml 
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Standard curve : IFN-gamma (1.56U/mJ-200U/ml) 
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Standard curve : IL-2 (1.56U/mJ-200U/mI) 
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Standard curve : IL-5 (15.6U/ml-2000U/ml) 
Plate 1 Stndard Curve 1 
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